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Quantitation of the intrarenal uptake of immune—complexes by macro-
phages in diffuse proliferative glomerulonephritis. N. W. Boyce, S.R.
Holdsworth, Monash University Department of Medicine, Prince Hen-
ry's Hospital, St. Kilda Road, Melbourne, 3004 Victoria, Australia.
The intrarenal processing of circulating immune—complex—like material
(CIC's) is traditionally attributed to resident glomerular mesangial cells.
To assess the contribution of infiltrating mononuclear cells to CIC
processing by diseased glomeruli, we have utilized an isolated perfused
kidney system (IPK) to quantitate the specific glomerular uptake of
C1C's [as zg of aggregated IgG per l0 glomeruli (tg/I04glom)]. The
IPK allows the study of direct uptake of complexes by the kidney itself,
and the effects of functional blockade of mononuclear phagocytosis on
the renal uptake of complexes. This preparation is devoid of influences
from other components of the reticuloendothelial system and allows
effective control over renal haèmodynamics, thus ensuring uniform
delivery of immune—complexes to the kidney in normal, macro-
phage—infiltrated and anti-macrophage serum—treated preparations.
Mononuclear cell infiltrated glomeruli from animals with diffuse prolif-
erative glomerulonephritis had a significantly augmented uptake of
CIC's (48.9 3.8 g/l04gloms : normal 11.8 0.6 zg/l04glom : P <
0.01). Specific blockade of mononuclear cell function by perfusion with
anti-macrophage serum prevented increased CIC uptake (12.8 1.2
sg/l04gloms : P < 0.01), but had no effect on the CIC uptake of normal
kidneys (13.1 1.2 g/l04gloms). Thus, in diffuse proliferative glomer-
ulonephritis the observed increase in the glomerular clearance of CIC's
was due to phagocytosis by mononuclear cells. This study indicates that
infiltrating, bone marrow—derived mononuclear cells may significantly
contribute to the glomerular handling of circulating immune aggregates
by nephritic glomeruli.
Monoclonal antibodies (McAbs) to non-glomerular basement mem-
brane (GBM) glomerular capillary wall (GCW) antigens in the rat. M.J.
Nicol, J.H. Miller, T.J. Neale, Department of Physiology, Victoria
University of Wellington and Wellington Clinical School of Medicine,
New Zealand. The role of fixed GCW antigens of non-GBM origin in the
immunopathogenesis of glomerulonephritis (GN) is a current subject of
intense research interest. Evidence has emerged which suggests that in
some experimental animal models of GN, discretely represented native
GCW antigens may directly bind antibody, not only producing a
granular pattern of immunofluorescence (IF) that in the past has been
equated with circulating immune complex deposition, but also func-
tional injury as expressed by proteinuria. We sought to define such
GCW antigens in Lewis rat glomeruli using McAb produced against
GBM-depleted glomerular plasma membranes (GMF). Balb/C mice
were immunised intrasplenically or intraperitoneally with GMF and
their splenocytes fused with NSI myeloma cells. Culture supernatants
from resulting hybridomas were screened for McAb reacting with GCW
antigens by micro-ELISA, using GMF as antigen, and by indirect iF
microscopy on normal Lewis rat kidney. From four fusion experiments
17 positive hybridoma clones have been isolated, all producing a
granular IF pattern of glomerular binding in vitro. To date three McAbs
have been examined in vivo; two bind to glomeruli producing granular
IF patterns at one hour. An 8M urea extract of rat glomeruli run on
SDS-PAGE was examined by Western immunoblotting using SC5, an
1gM McAb, as a probe. Reactivity was predominantly with protein
bands corresponding to 53, 120 and 175 kd. Intravenous injection of 10
mg of SC5 to normal Lewis rats produced an increase in urine protein
excretion. This study demonstrates that McAb can be produced which
define single discontinuously represented non-GBM, GCW antigens in
the rat.
Expression of macrophage differentiation antigens on human mesangial
cells. R. Andreesen, R.C. Atkins, Department of Nephrology, Prince
Henry's Hospital, Melbourne, Australia. It is believed that only a few
mesangial cells (3 to 5%) are bone marrow-derived and belong to the
heterogenous group of resident tissue macrophages (MO) the remainder
being of smooth muscle origin. In an attempt to further define the origin
and heterogeneity of mesangial cells, we have used monoclonal anti-
bodies (mAbs) against MO membrane antigens specific to maturation
stages beyond the blood monocyte (mo) level. MAX.I and MAX.ll
mAbs were developed by immunizing mice with mo-derived MO grown
on hydrophobic teflon foils and shown to be MO lineage restricted. PLP
fixed cryostat sections of normal human kidney were tested for reac-
tivity with MAX mAbs using a sensitive four—layer—immunoperoxidase
method. Commonly used mAbs to identify mo-MO (common
leukocyte, la-like, FMC32) were also employed. In normal mesangium
no ia FMC32 cells could be detected. However, a strong expression
of MAX.l and MAX.ll was seen on all mesangial cells, but not
endothelial or epithelial cells in the glomerulus. These antigens were
also expressed on smooth muscle cells of the afferent arterioles, but not
on other blood vessels in medulla and cortex nor in any other tissue
type studied (spleen, lymphnode, liver). As the MAX antigens are
restricted to site—specific MO, mainly of the exudate type in body fluids
but not expressed on Kupifer cells, microglia, granuloma cells, and free
and fixed MO in lymphnode and spleen, their detection on mesangial
cells and afferent arterioles is of great interest. Mesangial cells and
mature MO share several functions such as secretion of IL-l and
lipoxygenase products as well as phagocytosis. As both mesangial cells
and mo-derived MO exhibit these otherwise very restricted membrane
antigens, it is tempting to speculate that perhaps the entire mesangial
cell population, although devoid of any conventional MO membrane
antigens, belongs to the heterogenous family of end—stage matured MO.
Evidence for hydroxyl radical mediation of immune renal injury:
Abrogration of renal injury and neutrophil hydroxyl radical generation
by desferrioxamine. N. W. Boyce, S.R. Holdsworth, Monash University
Department of Medicine Prince Henry's Hospital, Melbourne 3004,
Australia. The acute phase of glomerular injury in a model of
antiglomerular basement—membrane antibody—induced glomerulone-
phritis (antiGBM-GN) in rabbits was shown to be neutrophil—dependent
using nitrogen mustard depletion studies. Administration of desfer-
rioxamine (DFX) prevented the development of proteinuria in this
model of renal injury [24 hr protein excretion (mean SEM); — antiGBM-
GN/DFX = 16.2 2.9mg cf. antiGBM-GN control = 271.5 92.2mg
P < 0.01]. Antibody binding levels, glomerular filtration rates,
circulating complement, neutrophil counts and glomerular C3 deposi-
tion, and neutrophil infiltration did not differ between DFX treated and
antiGBM-ON groups. In vitro assay systems to assess oxygen radical
production [superoxide anion (02 ) and hydroxyl radical (OH )] by
neutrophils activated via the interaction of antiGBM antibody, GBM
and complement were established. In these assays DFX inhibited OH
production by immunologically—stimulated neutrophils (ISN) [nM
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diphenol/hr/106 cells, mean 5EM, ISN/DFX 8 2 ef, ISN = 191
22 : P < 0.01], while production of 02 was uneflected InMO2 /hr/105
cells, mean sUM, ISN/DFX = 29.1 4.3 ef, ISN 32.6 t 2.5 1' >
0.05]. These studies demonstrate that the iron chelator, desfer-
rioxamine, can prevent neutrophil—dependent immune renal injury by
interfering with neutrophil function. Together, the in vivo and iu vitro
data strongly suggest that neutrophil—dependent immunological renal
injury is mediated via hydroxyl radical production by activated neutro-
phils within glomeruli.
A comparison of the kinetics of circulating and splenic auto-anti-
idiotypic antibodies after HgCI2 in the SN rat. iA. Savige, CM.
Lockwood, MRC Clinical Immunology Unit, Royal Post-graduate
Medical School, London, United Kingdom. The administration of the
polyelnnal activator HgCl2 (1 mg/kg i.p.) to Brown Norway (BN) rats on
days 0, 2, 4 and 7 resulted in the cyclical development of both direct
(1gM) splcuic plaque forming cells (PEt) specific for glomerular base-
ment membrane (GBM) (peaks at days 9 and 23) and circulating
anti-GBM antibodies (peaks at days II and 23—25). Anti-idiotypic
antibndies to anti-GBM antibodies were sought in the scruni of four SN
rats using the glomerolar eluate obtained from diseased rats. Fluted
antibody was radiolabelled(2.5 x 106 cpm 251. mcg'), pepsin—digested
and the resulting tF (ab)2 fragment used as a probe in a precipitation
assay with 4% PEG. Two peaks of serum auto-anti-idiotypic activity
were noted: at day 11(14,405 4221 cpm bound M so, cf 8375 536
at day 0; P < 0.01) and at days 21 to 25 (9715 1407 cpm; P NS).
Functional splenic auto-anti-idiotypic antibodies were demonstrated by
an increased number of PFC, when low concentration of GBM were
added to the plaquing mixture ("augmentation"), presumably as a
result of the displacement of anti-idiotypic antibodies from the surface
of the spleen cell, and reversal of inhibition of anti-GBM secretion.
Augmentation was noted in 14 of 18 spleens during days 9 to 11; 21 of
22 between days 12 and 22, and 10 of 16 during days 23 to 26. We
conclude that circulating auto-anti-idiotypic antibodies in a polyclonal-
ly—activated system demonstrate similar kinetics to corresponding
idiotypic antibody. The reciprocity demonstrated between the presence
of specific PFC and augmentation suggest that anti-idiotypic antibodies
may have a role in the mechanisms of cycling.
Mechanisms of fibrin deposition in anti-glomerular basement mem-
brane antibody induced glomerulonephritis in rabbits. PG. Tipping,
S.R. Holdsworth, Monnsh Department of Medicine. Prince Henry's
Hospital, St. Kilda Road, Melhourne, Victoria, 3004, Australia. Fibrin
is an important mediator of glomerular injury in anti-glomerular base-
ment membrane antibody—induced glomerulonephritis (anti-GBM ON).
The mechanisms involved in the initiation of fibrin deposition are
unknown. The involvement of the intrinsic and extrinsic coagulation
pathways was studied in rabbits developing anti-GBM ON. Glomerular
injury (proteinuria, plasma creatininc, and gloinerular crescent forma-
tion) was assessed in groups of six or eight rabbits on days 4, 6, 8 and
10 after the initiation of the disease and in a group of normal rabbits. All
parameters increased progressively over this time as a crescentie GN
developed. Olomerular fibrin deposition was assessed by im-
munofluorescence and 25! fibrinogen deposition, and glomerolar
maerophage ingress by glomerular cell culture. Glomerular macrophage
ingress (maximal on day six) clearly preceded the onset of fihrin
deposition. Nephritic glomeruli contained augmented amounts of
procoagulant activity (PCA), which activates the extrinsic coagulation
pathway. Highest levels of PCA were found on day six, coincident with
the maximal macrophage presence. Glomerular PCA subsequently
declined as the numbers of glomerular macrophages declined. Glomer-
ular deposition of Factor VIII related antigen, a marker of intrinsic
pathway activation, was assessed by immunofiuoresceoce and found to
be present in Bowman's space only in the late stages of this disease.
These observations suggest a role for extrinsic pathway activation, via
PCA, in the initial stages of glomerular fibrin deposition in anti-GBM
ON. Glomerular maerophages arc the most likely source of this PCA.
Intrinsic pathway activation may he involved in flbrio deposition in
Bowman's space in the later stages of the disease.
Decomplementation studies in anti-tubular basement membrane (TBM)
antibody associated tubulointerstitial nepbritis (TIN). K. M. Bannister,
C.B. Wilson, Research Institute a/Scripps Clinic, La Jolla, California,
fJSA. A role for complement in the development of anti-TBM antibody
associated TIN in the rat has been suggested by the finding of (I) linear
circumferential C3 along TBM of tubules involved in 'FIN and (2) a
polymorphonuelcar lcukoeyte influx early in the disease. This study
examined the functional role of complement as a mediator in the
development of TIN resultiog from passive transfer of anti-TBM
antibody to normal Brown—Norway (SN) rats. Lewis (LEW) rats
immunized with BN renal basement membrane and adjuvants develop
high titer circulating antibody reactive with BN, but not LEW TBM
(radioimmunoassay (RIA) and immunofiuorescence). This allo-anti-
body was capable of transferring histological lesions of TIN within 24
hours when as little as 3 ml of pooled sera was injected i.v. into SN
recipients. Eleven SN rats received 7 ml i.v. of such LEW immune sera
in two divided doses on day 0. Six of these rats were injected i.p. with
purified cobra venom factor (CVF) (30013/kg) on days I to 5 (sacri-
fice). Serum C3 levels were estimated on days 0, 2 and 5 hy immuno-
diffusion in gel. TIN (area involved) was scored by single blind
examination of ten step kidney sections from each rat. C3 depletion
with CVF resulted in a greater than 80% reduction in area of destructive
TIN lesions and a marked decrease in total numbers of associated
multinucleate giant cells. (CVF group 21 vs. controls 293) This finding
was not due to differences in antibody bound as the quantity of IgO
elutcd from the kidneys of CVF treated rats was not significantly
different from that from the control animals. Complement therefore
plays an important functional role in this new model of anti-TBM
antibody associated TIN.
Australian multicenter trial of cyclosporine A in renal transplantation:
Preliminary report. B. Hall, Australian Multiceater Study Group.
Cyclosporine A (CSA) therapy alone has been compared to prednisone,
azathioprine and antilymphoeyte globulin (ALO), and CSA for three
months followed by azathioprine and prednisone (CSAZA) in a pro-
spective randomized trial. The aim of the study was to test the
effectiveness of the two CSA arms in preventing first cadaver graft
rejection and to compare the morbidity and mortality associated with
these arms with conventional therapy. Long term morbidity, especially
relating to skin cancer, was also to be examined. CSA was commended
as a 5 mg/kg iv. bolus and then 4 mg/kg i.v. daily until oral CSA was
tolerated at 12 mg/kg, reduciog to 7.5 mg/kg at nine weeks. Short term
CSA was given in the same fashion for 100 days; if there had beeo no
clinical rejection for 28 days and if a renal biopsy showed no rejection,
the patient was changed to AZA. After 24 months there was no
significant difference in graft survival. Acute rejection was the main
cause of graft loss in all groups.
AZA CSA CSAZA
Patient survival at 12 months 90.1% 97.3% 94.5%
Graft survival at 12 months 76.5% 81.9% 83,9%
'total patients entered 109 100 108
Total at 12 months 57 60 55
There was a significantly higher mortality in the AZA group, compared
with both CSA groups. P 0.027. The most common cause of death
was vascular disease in older patients (>55 years). Infection was more
common in the AZA group. The only death from malignancy occurred
in the AZA group, adenocareinoma, primary unknown. There were no
lymphomas. Two deaths from encephalopathy and coma occurred in
the CSA group due to an unknown cause. No grafts were lost in the
change from CSA to AZA. In 61 patients on CSAZA there were only
four graft losses, three with established rejection and one following a
renal biopsy, which showed oo rejection. Six patients on CSA had
prolonged oliguria > 38 days and all had reversal of renal failure on
withdrawal of CSA. Seven patients on AZA changed to CSA, two
because of uncontrolled rejection and five because of bone marrow
suppression. Ooly one subsequently lost their graft from rejection. One
patient continued on CSA and AZA. Serum ereatioine at two months
were 250 ISO j.smol/liter in CSA; 225 t 135 io CSAZA and 201 162
in AZA. At 12 months those levels were 195 95, 140 64, and 169
106, respectively. In this interim report it is not possible to demonstrate
a difference in bog—term outcome between any of the treatments used.
Be novo thrombotic microangiupathy (TMA): Occurrence and differ-
ential diagnosis in three transplant patients. J.P. Dowliog, A.F. d'Apice,
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P.S. Kincaid—Smith, Departments of Anatomical Pathology and
Nephrology, The Royal Melbourne Hospital, Melbourne, Australia.
TMA, which has previously been reported as a de novo or recurrent
insult in renal transplants, developed in three renal allograft patients
and was associated with significant impairment of graft function. Patient
I, a 26-year—old female developed clinical and histological evidence of
rejection four days after receiving her third allograft; immunosuppres-
sion consisted of cyclosporine A (Cy A), azathioprine and low dose
prednisolone. Glomerular microthrombosis was noted on her fourth
post-transplant biopsy, which also showed rejection—related
glomerulopathy. Patient 2, a 22-year—old female had an acute febrile
episode with graft tenderness two days post-graft. Immunosuppression
was with Cy A, azathioprine and low dose prednisolone. Hemoglobin
and platelets fell during the episode and biopsy showed florid glomer-
ular and arteriolar TMA; recovery of function followed cessation of Cy
A and the administration of subsequent plasmapheresis and hepariniza-
tion. Patient 3, a male, 59-year-old who had been transplanted six years
previously, developed acute renal failure following renal angiography
for peripheral vascular disease. Immunosuppression was with
azathioprine and prednisolone. Renal failure recovered incompletely
with heparin and plasmapheresis and a repeat biopsy showed evidence
of continuing, but mild TMA. Patients 1 and 2 may have developed
TMA as a complication of Cy A therapy, with patient 1 having biopsy
evidence of interstitial scarring of Cy A toxicity type and patient 2
showing no inflammatory change on biopsy to indicate hyperacute
rejection. Patient 3, who did not receive Cy A, had a very strong
temporal relation of TMA development to the use of radiocontrast dye,
a very unusual cause of such a reaction. It is suggested that, as in the
non-transplant patient with TMA, causes other than severe or
hyperacute rejection such as drugs, chemical substances, viral or
bacterial infection should be sought in transplant recipients.
Improvement of early renal ailograft function with verapamil. K.A.
Duggan, G.J. Macdonald, J.A. Charlesworth, BA. Pussell, Prince
Henry Hospital, Sydney, Australia. Verapamil has been shown to
prevent acute renal failure in animal models if administered prior to the
insult, and it may, therefore, have a role in the preservation of
cadaveric renal tissue for transplantation. To investigate its usefulness
in this situation, 20 renal donors were randomly allocated to treatment
or control groups. Both groups received a standard preparation for
nephrectomy: (i) rehydration with 0.9% saline; (ii) I g methyl
prednisolone and 20 g mannitol intravenously one hour pre-nephrecto-
my; (iii) 10,000 units of sodium heparin and 100 mg phenoxybenzamine
immediately before ceasing ventilation. In addition, the treatment group
received 20 mg verapamil (Isoptin, Knoll Pharmaceuticals) intrave-
nously at this point. The kidneys were perfused in situ with Ross'
Solution, resected en bloc and then maintained on a Waters' oxygenator
MOX100C perfusion machine until tissue matching and allocation were
performed. Post-transplant management was according to the recipient
hospitals' usual protocols. Early graft function was assessed by serum
creatinine and urine output on days one and seven post-transplant, and
by the need for dialysis in the first post-transplant week. Results for the
two groups were compared by analysis of variance as determined by the
F distribution. The urine outputs for the treated group were significantly
greater than for controls (2208 635 ml compared with 1168 237 ml,
P < 0.01) on day one and the serum creatinine concentrations were
lower (0.74 0.05 and 0.82 0.08, respectively, P < 0.05). This
difference was not maintained at day seven, nor was it reflected in the
need for dialysis during the first post-transplant week with 13 patients in
each group requiring dialysis. It is concluded, therefore, that verapamil
has a role in renal allograft preservation but that its optimal dosage and
route of administration have yet to be determined.
Renal autotransplantation for severe loin pain hematuria syndrome.
A.G.R. Sheil, L.S. Ibels, M.A.B. Thomas, J.C. Graham, Department
of Surgery, University of Sydney and Renal Unit, Royal North Shore
Hospital, Sydney, Australia. The Loin Pain Hematuria syndrome
describes the association of recurrent renal pain, hematuna and abnor-
malities of the intrarenal vasculature. In some patients loin pain is
incapacitating. In such patients most forms of therapy have proved
unsuccessful, though nerve block procedures and the operation of renal
denervation have sometimes provided temporary relief. We report here
three patients with this syndrome who had unremitting severe pain. In
two the loin pain was unilateral and predominantly so in the third. All
were narcotic—dependent for relief of pain and required repeated or
persistent hospitalization. In all three patients renal function, excretion
urography, and angiography were normal and renal biopsies revealed
deposition of the third component of complement in renal arterioles. All
were treated by renal autotransplantation, the symptomatic or more
symptomatic kidneys being completely excised and reimplanted in the
ipsilateral iliac fossa. Post-operative excretion urography was normal
for the transplanted kidneys. Follow—up was 11 to 14 (mean 13) months.
So far, all patients have had complete relief of pain from the involved
kidney despite recurrence of hematuria. It is suggested that the pain of
the syndrome is mediated through the autonomic system and that
complete nerve section accompanying renal autotransplantation ex-
plains relief of pain. It is considered that reinnvervation is unlikely. It is
too early to determine if this major procedure is justified for treatment
of selected patients with incapacitating renal pain due to the Loin Pain
Hematuria syndrome, but the early results are encouraging.
Hyperparathyroidism following renal transplantation. J.K. Dawborn,
W.F. Heale, L. Kotler, P.J. Miach, F. Mclnnes, Austin Hospital,
Heidelberg, Victoria, Australia. Six patients were identified five to ten
years after renal transplantation with marked hypercalcemia (2.83
0.09 mmol/liter) and raised PTH 1-84 (33 8.2 (SD) pmol/liter; N = 10
2). All had hyperparathyroidism (HPT) prior to transplantation (alk
phos 510 194 lU/liter) and had not been treated. Alk phos was normal
in all patients after two years but PTH levels remained elevated.
Hypercalcemia and hypophosphatemia developed between six to 12
months post-transplant. Three patients underwent parathyroidectomy
(total wt> 3 g). Hypercalcemia and HPT were corrected by day three.
All patients were normocalcemic after one week and required no
medication. Biochemical parameters were compared with 43 patients
transplanted for > 1 year with a creatinine clearance > I ml/sec. Five
patients had moderate hypercalcemia and HPT two to four years after
transplantation (calcium 2.68 0.04; PTH 15.3 1.5). 38 patients were
normocalcemic. Thus persistent HPT was seen in II out of 49 patients;
of 20 patients transplanted for less than five years, six had hyperpara-
thyroidism. In most patients PTH returns to normal within 12 months of
transplantation. The reason for failure of involution in these patients is
not clear. The appearance of hypercalcemia 12 months after transplant
may coincide with reduction in prednisolone, the resolution of PTH
resistance or repletion of bone calcium. After 12 months the chance of
resolution of HPT is small. These patients are exposed to the same risks
avs patients with 10 HPT and should be evaluated in a similar way with
regard to parathyroid surgery.
Pregnancy in renal transplant recipients. J. McDowell, J. Horvath, A.
Korda, D. Tiller, B. Hall, G. Duggin, J. Johnson, J. Solomon, R. Sheil,
J. May, Departments of Renal Medicine and Obstetrics and Gynecol-
ogy, Royal Prince Alfred Hospital, Camperdown NSW, Australia. The
abnormal reproductive function of women with renal insufficiency on
hemodialysis is reversed by a good functioning graft. It has been
reported that return of menstrual function and ovulation is best corre-
lated with the level of renal function post-transplant. Since 1967 there
have been 714 transplants, of whom 193 were women in the reproduc-
tive age. Nine women who had been transplanted for seven to 103
months had 15 pregnancies. All patients were on prednisone and
azathioprine. The patients were aged 20 to 35 years and the serum
creatinine was 70 to 573 .smol/liter when pregnancy was diagnosed.
There was no recent documented rejection. Six of the nine patients had
controlled hypertension. Proteinuria was present in 10 of 15 pregnan-
cies. There was one therapeutic abortion on social grounds and the
remaining 14 pregnancies resulted in one stillbirth and 14 viable infants
(one set of twins). The stillbirth occurred in the only patient with a
creatinine in excess of 140 mol/liter (573 mol/liter) and the patient
subsequently returned to dialysis. In the remaining patients there was
either no change or a decrease in serum creatinine during pregnancy, no
episode of rejection, and no ureteric obstruction during pregnancy.
Complications attributable to pregnancy were urinary tract infections in
five pregnancies. Of the 14 live born infants, all were above the 10th
percentile for birth weight adjusted for gestation. One infant developed
meningitis at day eight and subsequently had severe mental retardation,
but the remaining 13 infants showed no abnormalities and have had
normal development. Pregnancy following cadaveric transplantation
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remains unusual, but women with good renal function who conceive
have a good chance of a relatively uncomplicated pregnancy and a
normal neonatal outcome.
Correlation of clinico-pathological parameters with outcome using
multiple regression analysis in lupus nephritis. B. Leaker, P.
Kincaid—Smith, Department of Nephroiogy, The Royal Melboarne
Hospital, Parkville, 3050 Victoria, Aostralia. Previous authors have
attempted to predict outcome using clinico-pathological parameters
recorded at initial renal biopsy using multiple regression analysis. The
lack of prognostic information provided by histological data has led to
the value of renal biopsy being questioned. This study has examined the
power of data obtained serially to predict outcome using the above
analysis. The clinical and histological parameters tesled at biopsy and
correlated with outcome were age, sex, serum creatinine, activity
score, crescentic lesions, chronicity score, and interstitial sclerosis. At
first biopsy (N 97) there were significant correlations with activity, R5
9.6, P < 0.001, and crescents R2 = t3, P < 0.01. At second biopsy
(N = 63), median time 11 months, only serum creatinine correlated with
outcome R2 = 11, P < 0.05. At subsequent biopsies (N = 55), median
36 months, interstitial sclerosis R2 23 P < 0.001 and activity R2 = 32,
P < 0.001 correlated with outcome. A model of "best fit" to test the
above parameters as predictors of outcome was derived. Activity and
crescents R2 13, P < 0.01, on first biopsy, serum creatinine and
chronicily score R2 = 75, P < 0.05, on second biopsy, activity and
chronicity scores R2 13, P < 0.05, on subsequent biopsies were the
most significant predictors of outcooic. The above results confirm
convictions that both clinical and pathological data are able to predict
outcome, albeit weakly. tlistological parameters in this study were
more powerful predictors of outcome than clinical data alone. Predic-
tive models of outcome based on data obtained at a single entry point
should be interpreted with caution in a variable and unpredictable
disease.
Does paracetamol cause renal papillary necrosis or cancer of the kidney
or urinary tract? M. McC]reclie, f/I. Stewart, Renal Unit, Deportment
of Medicine, Wesimead Hospital, Sydney, Aostralia. The risk of
developing disease conferred by consumption of either phenacetin or
paracetamol (at least 1 kg) was calculated from data acquired by
questionnaire from patients with renal papitlary necrosis (RPN; 80 f, it
m), cancer of the kidney (CaK; 131 f, 229 in), renal pelvis (CaP; 82 f, 58
m), ureter (CaU; 16 f, 39 m) or bladder (CaB; 162 t') and age—matched
controls taken from a random sample of the population (734 f, 652 m).
The data were stratified by sex, consumption of the other analgesic and,
for the cancers, smoking. Each analysis was adjusted for the effect of
these factors. The risk of RPN was increased seventyfold by consump-
tion of phenacetin, but no increased risk was conferred by paracetamol
when exposure to phenacetin was controlled. Phenacetin also increased
the risk of CaK, CaP and CaB but not for CaU. By contrast,
paracetamol did not significantly increase the risk ratio for any of these
cancers. Mantel—Haenszel risk ratios (95% confidence limits) for:
RPN CaK CaP CaIJ CaB
Phenacetin 70 2.0 7.2 1.1 2.0
(50—134) (1.3—3.0) (4.7—11.0) (0.4—3.0) (1.1—3.5)
Paracetamol 0.1 1.0 1,1 1.8 0.7
(0—0.3) (0.6—1.6) (0.7—2.0) (0.8—4.4) (0.4—1.3)
While the etiological relationship of phenacetin to RPN, CaP and CaB
(but not CaU) is confirmed, and that to CaK is once again suggested by
these data, paracetamol cannot be implicated in the pathogenesis of
either RPN or any of the cancers examined here.
Rapid improvement in lupus glomerular lesions following intensive
plasma exchange B. Leaker, G.J. Becker, J.P. Dowling, P.S. Kincaid-
Smith, Department of Nephrology, The Royal Melbourne Hospital,
Parksille, 3050, Victoria, Australia. Few authors have examined the
effect of PE in severe lupus nephritis and there have been no previous
reports of the effect of PE in renal histology. We report our experience
of intensive PE in the treatment of 12 females with severe diffuse
proliferative lupus nephritis. All had active disease with crescentic
lesions demonstrated on biopsy imnsediately before PE. 'i'wetve pa-
tients (median age 21 yrs) received PE for a period between six weeks
and three months and were followed for a period of one to 84 months
(median 24) after cessation of PE. Nine patients were also treated with
high dose steroids, three patients with low—dose steroids and most
patients also received cytotoxic therapy. There were no complications
attributable to PE. Two patients in the high dose group died; one patient
who was non-compliant progressed to ESRF; one patient suffered a MI
and died in left ventricular failure. Renal function was improved in five
patients and remained normal before and after PE in live patients. One
patient was stable for 12 months, but returned in ESRF after two years
loss from follow—up. Eight of the 12 patients were biopsied immediately
after a course of PE. All but one patient (low steroid group) showed
considerable dimunition of histologic activity with resolution of cres-
centic lesions. PE may accelerate such resolution over conventional
therapy, prevent subsequent sclerosis, and preserve functional renal
tissue.
Triamterene induced cylinduria and crystalluria: An animal model. B.
Leaker, K.T. Woo, D. Birch, K. Fairley, Department of Nephrology,
The Royal Melbourne Hospital, Parkville, 3050, Victoria, Australia.
Renal failure, interstitial nephritis, renal calculi, and the development of
distinctive urinary casts have been reported following triamterene
therapy. We present an animal model of triamterene induced cylinduria
and erystalluria. Twelve female rats (Hooded—Evans strain, mean wt
190 g) were randomly allocated to treatment (N = 6) or control group(N = 6). Rats were gavage fed twice daily for five days with I ml
triamterene suspension (5 mg/mI triamterene, 200 mg/mI ascorbic acid
with 200 mg/mI compound traganath suspension in distilled water) or
with 1 ml control suspension. On the fourth day a 12 hour urine
collection was obtained. On the fifth day rats were sacrificed. Renal
tissue was mounted in OTC compound and snap frozen in liquid
nitrogen. Frozen sections and unspun urine were examined under phase
contrast microscopy and polarized light. All triamterene treated rats
demonstrated crystals and casts in unspun urine. The casts were of
waxy yellow appearance and highly refractile under polarized light. No
such casts were seen in control specimens. Casts were visible to the
naked eye as yellow streaks in the papilla on freshly sectioned kidney.
Examination of frozen sections revealed abundant cast deposition in the
large collecting ducts and papillae of all triamterene treated rats. The
casts were similarly highly refractile under polarized light. No casts
were seen in cortical or outer medulla areas. No casts were seen in
control animals. We suggest that such east formation may cause urinary
obstruction and lead to renal failure. As triamterene is the most widely
prescribed diuretic in the USA, these findings are of potential signifi-
cance.
Sexual acquisition of a urinary tract infection in a man. R.R. Bailey,
BA. Peddie, C.P. Swainson, D. Kirkpatrick, Department of Nephrol-
ogy, Christchurch Hospital, Christchurch, New Zealand. Sexual inter-
course is an important risk factor for acute cystitis in women. This
association is reflected in the popular term 'honeymoon cystitis'.
intercourse probably predisposes women to urinary tract infection by
facilitating the entry of organisms from the urethra into the bladder,
rather than by their veneral transmission. A 37-year--old man was
admitted with a 24 hour history of frequency, dysuria and hematuria,
and subsequently developed acute pyelonephritis. The urine contained
>jfi9 WBC and RBC/liter and was infected with Escherichia coli. He
had a normal urinary tract and renal function. He recovered rapidly
with triosethoprim therapy. Follow—up urine cultures were sterile,
Three days before his symptoms developed, his wife presented with a
seven day history of frequency and dysuria and the more recent onset
of hematuria and suprapuhic pain. Her urine was infected with E coli
and was eradicated with trimethoprim. Before the wife developed her
symptoms, the couple were having vaginal intercourse nightly and this
continued for the first three days of her symptoms. The E coli isolates
from both patients had the same biotype (using the API 20 F system l'or
identification of enterobacteriaceae), an identical antibiogram when
tested against 10 antimicrobial agents and the same serotype (02.H4).
The temporal sequence of events and the bacteriological data argue
strongly for the sexual transmission of this organism from the wife to
her husband.
Contributions of indoxyl sulfate (IS), Hippurate (HIP) and o-OH
Hippurate (oHH) to impaired tigand binding by uremic plasma. P.F.
Abstracts 617
Gulyassy, E. Jarrard, L. Stanfel, Nephrology Division, University of
California, Davis, California, U.S.A. Several aromatic acids which
may accumulate to high levels have been implicated as the cause of the
impaired binding of drugs and endogenous ligands by uremic plasma.
We have developed reliable HPLC methods to measure plasma IS,
HIP, and oHH, correlated levels of each acid in plasma of 18 azotemic
patients with binding of a model probe, 14 C-salicylate (SAL), and
attempted to induce the binding defect in normal plasma by addition of
IS and HIP. Ranges of creatinine (CR), IS and HIP were 292 to 3801, 22
to 240, and 27 to 897 tmol/1iter. The oOH level was undetectable (N =
12) or low (<70, N = 3) except when SAL level was also elevated (N =
3). 14 C-SAL binding was negatively correlated with plasma CR, IS,
and HIP, but the depression in uremic plasma was far larger than that
of normal plasma, diluted to equal albumin concentration and spiked to
azotemic levels of IS or HIP. To evaluate the additive effect of IS and
HIP, 14 C-SAL binding was compared for nine pairs of uremic
plasma:normal plasma spiked with both IS and HIP to the level of the
azotemic plasma. 14 C-SAL binding in the spiked normal plasma was
only slightly reduced (compared to normal, unspiked plasma) by 3.2
SD 1.1%. The 14 C-SAL binding by azotemic plasma was 17.9 SD
7.6% below the control binding. Conclusion: the ligands causing most of
the impaired ligand binding in uremic plasma remain to be identified.
Renal disease in diabetics: Place of renal biopsy. K.L. Lynn, T.J.
Frendin, R.R. Bailey, C.P. Swainson, R.J. Walker, Department of
Nephrology, Christchurch Hospital, Christchurch, New Zealand. The
place of renal biopsy in diabetics with clinical renal disease is unclear.
From August 1974 to January 1985, 53 diabetics (26 men; 7 Maoris),
aged 45 (SD 15) years, had a renal biopsy and were followed. The known
duration of diabetes was 12 (SD 9) years; 39 patients had retinopathy, 33
used insulin (IDDM) and 44 were hypertensive. Indications for biopsy
were: nephrotic syndrome (24), proteinuria (23), renal insufficiency (5)(2 ARF), and hematuria (1). Plasma creatinine was 0.22 (SD 0.18)
mmol/liter and protein excretion (ARF excluded) 3.4 (sD2.5) g/24 hr.
Diabetic nephropathy (DN) was demonstrated in 39 patients, but in 14
(6 without proteinuria) the findings were: not diagnostic (6), glomeru-
lonephritis (GN) (4), acute pyelonephritis (1), papillary necrosis (1).
Retinopathy (35 of 39 vs. 4 of 14; P < 0.001), IDDM (29 of 39 vs. 4 of
14; P < 0.05) and Maori race (7 of 39 vs. 0 of 14) were more common
with DN. Patients with GN had a shorter duration of diabetes (3.8 (SD
2.1) years; P < 0.001). Of the 39 patients with DN followed for 25.7 (SD
22.8) months, 17 are dead (8 myocardial infarction, 6 uremia, 2 sepsis,
1 stroke), 9 are on dialysis and 13 are alive (plasma creatinine 0.14 (SD
0.06) mmol/liter). The one and five year cumulative renal survival rates
were 76% and 27%, respectively. In patients with IDDM of >10 years
duration, retinopathy and proteinuria renal biopsy appears unnecessary
to diagnose DN. DN, especially with nephrotic syndrome, has a poor
prognosis.
Comparison of a single dose with a five day course of trimethoprim for
asymptomatic (covert) bacteriuria of pregnancy. R.R. Bailey, BA.
Peddie, V. Bishop, Department of Nephrology, Christchurch Hospital,
Christchurch, New Zealand. The benefits of detecting and treating
asymptomatic (covert) bacteriuria in pregnancy are welt established.
Single—dose antimicrobial therapy is now widely used for the treatment
of uncomplicated urinary tract infections. Most reported studies with
single dose therapy have been done in non-pregnant women. In the
latter context, two of the most successful drugs used in single dose
regimens have been co-trimoxazole and trimethoprim alone. A prospec-
tive, randomized study was undertaken to compare the efficacy of a
single 600 mg dose of trimethoprim with a five day course of trimetho-
prim (300 mg, 24 hr) for the treatment of asymptomatic bacteriuria in
women between 16 and 30 weeks gestation. Sixty women with asymp-
tomatic bacteriuria were allocated to treatment, with 27 of 30 being
cured with single dose trimethoprim, compared with 24 of 30 given a
five day course. One woman vomited the single dose. She was one of
the three women who failed treatment with single dose trimethoprim.
All three had a normal intravenous urogram. Of the six women who
failed a course of treatment with trimethoprim, four had an intravenous
urogram and two of these were found to have unilateral refiux nephrop-
athy and one a renal calculus. No detrimental effects on the pregnancy
outcome were noted. Single dose therapy should be considered as the
treatment of choice for covert bacteriuna in pregnancy.
Calculation of the apparent affinity constants for aluminium and
transferrin. M. Nicholson, J.H. Coates, M. Cochran, Department of
Medicine, Flinders Medical Centre, South Australia 5042 and Depart-
ment of Physical Chemistry, University of Adelaide, South Australia
5000. Since transferrin is a specific protein carrier for aluminium in the
ECF with stoichiometric binding at two sites on the molecule, it is of
interest to characterize the apparent affinity constants (K'a) for the
Al-transferrin complex. This can be accomplished by examining the
equilibrium concentrations of transferrin, aluminium, and citrate, using
the citrate as a competing ligand. The concentration of the Al-transfer-
rin complex can be measured by differential spectrophotometry at 240
nm. Aliquots of sodium hydrogen citrate (20 nmole), and aluminium
chloride (20 nmole) were progressively added to a solution of transferrin
(100 nmole) at pH 7.4, and A240 measured after equilibration. The
experiment was repeated at different citrate concentrations giving a
curve for each concentration. Knowing the Ka' for aluminium and
citrate ions and the aluminium ion hydrolysis constants, it was possible
to derive values for the differential molar absorptivity at 240 nm and the
Al-transferrin K,,'. The latter were established as =10I3M_I. These very
high K,,' values between aluminium and transferrin imply that transfer-
rin will act as a sink for the metal in the ECF, inhibiting its removal by
any dialysis technique. The concentration of "free" aluminium will
always be very small under physiological conditions, except where
there is biological alteration of the Al-transferrin complex. The possi-
bility exists that the complex may deliver aluminium to specific sites
causing interference with the metabolism of other trace elements.
Sexual dysfunction in home hemodialysis patients. K.L. Lynn, A. L.
Buttimore, B. Hill, Department of Nephrology, Christchurch Hospital,
Christchurch, New Zealand. The incidence of sexual dysfunction was
evaluated in home hemodialysis (HHD) patients seen at an annual
review. Forty—two HHD patients (15 women, 27 men; 6 diabetics), aged
25 to 70 (mean 47) years, were studied. They had dialysed three times
weekly for 8 to 10 hours for 12 to 133 (mean 41) months. None were
taking antihypertensives. Thirty—seven patients had a healthy sexual
partner. Of the 10 women aged <55 yr, four had amenorrhoea, four had
abnormal menstruation and two had normal periods. Twelve of 27 men
and two of 15 women reported normal libido. For men with normal
libido, plasma testosterone concentration was higher (17.5 [SD 6.41 vs.
12.6 [SD 5.1] nmol/liter; P < 0.05). Seven men (26%) had normal
potency. Plasma testosterone concentrations were higher (19.2 [SD 5.11
vs. 13.0 [SD 5.61 nmol/liter; P < 0.02) and plasma zinc concentrations
lower(14.3 [SD 2.11 vs. 16.8 [SD 3.7] /Lmol/liter, P <0.05) in potent men.
Plasma prolactin concentration and age were not significantly corre-
lated with libido or erectile function. Four patients had coitus monthly,
three more than monthly, six weekly, four more frequently and 25
never. Twenty—five pairs, five partners and two patients rated their sex
lives as satisfactory, while in five pairs both were dissatisfied. HHD
patients have a high incidence of sexual dysfunction which appears to
be well tolerated.
Nutritional assessment in patients on long—term continuous ambulatory
Peritoneal dialysis (C.A.P.D.). P.J. O'Connell, L.S. Ibels, MA.
Thomas, D.C.H. Harris, J. Kesseihut, K. Heathcote, Department of
Renal Medicine, Royal North Shore Hospital, Sydney, N.S.W., Aus-
tralia. In order to assess the effects of C.A.P.D. on nutritional status
and to see what effects age, sex, and time had on these changes,
anthropometric, dietary, fasting biochemical, and hematological studies
were performed up to eighteen months after commencing C.A.P.D.
There were 66 patients (39 females and 27 males) aged eight to 68 years
(mean 46.6 years) and 788 patient months were studied. Age was
arbitrarily divided into < 50 years (33 patients) or > 50 years. Results
were assessed by using multiple linear regression and multivariant
analysis. There was a significant (P < 0.05) increase in ideal body
weight (mean increase 14%), triceps skinfold thickness (TSF) (mean
increase 43%), cholesterol (6.7 1.4 to 7.5 3.0 mmol/liter) and
triglycerides (2.7 1.3 to 3.8 2.7 mmol/liter) with time. Ideal weight
and triceps skinfold thickness was signifcantly greater in the older
patient (> 50 years). TSF and cholesterol were greater in females and
midarm muscle circumference (MAMC) was greater in male patients.
Urea and urea generation rates were constant, but were significantly
greater in males. Serum albumin (37 4 g/liter), absorbed glucose (560
g 226), peritoneal protein loss (7.7 g 2.9) and serum transferrin (246
618 Abs/rot/s
t 60 g%) remained constant. Using correlation analysis, ideal weight
had a significant correlation with increases in TSP, triglycerides,
cholesterol and absorbed glucose. In conclusion, long—term C.A.P.D. is
associatcd with an incrcasc in body fat and oftcn results in a weight
increase ahove ideal hody weight. There is an increase in cholesterol
and triglycerides which correlates with an increase in ideal body weight.
Nutritional status of home hemodialysis patients. K.L. Lynn, AS.
Toletnoitogo, BA. Sooders, Deportment of Nephrology, Chris/church
Hospitol, Christchurch, New Zeolond. Malnutrition is said to bc
common in renal failure but there are few stndies of home hemodialysis
(HHD) patients. We stndied 32 HHf) patients (23 men), aged 50 (SD 14)
years, who had dialyscd thrcc timcs wcckly (mean 23.1 hr/wk) for Ito
138 months. No formal dietary restrictions were imposed. Body mass
index (BMI), arm muscle circumference AMC) and triceps skin fold
thickness (1SF) were measured using standard techniques. Diet was
assessed by three day dietetic diary and interview. Mean caloric intake
was 29.4 (so 10.7) keal/kg; 18 (56%) patients had energy intakes less
than the 25th percentile for normals. Protein, vitamin C, and folate
intakes were above recommended minimum safe intakes. Intakes were
less than recommended for calcium in four (13%) patients, iron in one
(3%) and vitamin B1, in two (6%). One—third of both sexes had BMI
(kg/m2) <25th percentile for normals, hut none were <80% of ideal
body weight. AMC was normal for all patients but TSF was <60% of
standard in eight men (35%) and three women (33%). No
anthropometrie measurements were correlated with energy, protein, or
fat intake. l.aboratory tests were not useful in predicting protein intake.
Neither nutritional intake nor anthropometric measurements were
correlated with the duration of HHD. There was little evidence of
malnutrition and wasting in this group of well rehabilitated HUD
patients.
Lymphokine (MW) production by glomerular T-lymphocytes in exper-imental glomerulonephritis. NW. Boyce, P.C. Tipping, SR.
Holdsworth, Monosh University Deportment of Medicine, Prince Hen-
cv's Hospitol, Melbourne, 3004, Austrolio. Glomerular T-lymphoeyte
infiltration has recently been demonstrated to precede glomerular
macrophage influx in a preimmunized model of anti-glomerular
basement—membrane antibody—induced glomerulonephritis (antiOMB-
UN). In the current study, the functional role of these glomerular
I-lymphocytes in directing maerophage localization was sought by
measuring their production of maerophage migration inhihition factor
(MIF). MtF activity in supernatants from culture isolated glomeruli was
measured in a conventional capillary tube bioassay. Glomerular T-
lymphocytes (OXl9 positive cells) were maximal (1.95 0.19
eells/glomerular cross section, e/ges) 24 hours atier injection of
antiGBM antibody into sensitized animals. Seventy—two hours after
antibody injection, I-lymphocyte numbers were reduced (1.02 t 0.14
e/ges) while maerophage accumulation was maximal (at 24 hrs 4.2 1.3
macrophages /glomerulus (m/g) : at 72 hrs 19.8 3.7 m/g). MIF activity
was only detected in supernatants from T-lymphocyte infiltrated
gtomeruli; (12 hrs 40.8 4.32% migration inhibition: 24 hrs 45.11
4.11% migration inhibition: 48 hrs 38.24 3.53% migration inhibition:
72 hrs 20.86 3.85% migration inhibition, all P < 0.05). Control
glomeruli from normal animals, preimmunizcd animals given normal
sheep globulin, preimmunized animals given anti-GEM antibody and
eyelosporin A and non-preimmunized animals given antiGBM antibody
did not contain glomerular I-lymphocytes and their supernatants con-
tained no MIF activity, This data indicates that the glomerular I-
lymphocytes in preimmunized antiGBM UN are sensitized cells which
release MIF, and thus may direct glomerular macrophage localization in
this model of antibody induced glomerulonephritis.
Renal dendritic cell accumulation in lupus ncphritis. I).H. J-Iooke,
A.B. Suleimon, N.M. Thomson, B.C. Atkins, Deportmnents of'Nephrol-
ogy, Prince Henn's 1-Jospitol, Mclhoornc, Austrolio, ond Ilospitol
Besor, Koolo J.ompor. We have recently characterized the glomerular
and interstitial leueoeytic infiltrate in human glomerulonephritis using
inonoelonal antibodies as specific markeis of teueoeyte subsets. Lupus
nephritis has a marked interstitial leueoeytie infiltrate and the current
study examines the renal interstitial dendritie cell (RIDC) in biopsies
from patients with lupus nephritis. Since dendritie cells in other organs
are known to play an important role in antigen presentation and immune
response induction, this study was designed to determine whether
intrinsic RIDC accumulation is a feature of the immune response in ibis
disease. Renal tissue from 27 individuals (13 normal kidneys and 14
lupus nephritis biopsies) was stained by a three—layer immunoper-
oxidase technique using monoelonal antibodies to different antigenie
determinants of the leucocyte common molecule. The first (10.89.4)
labels all nucleated hemopoietic cells including RIDCs. The second,
(PHM1t, labels all nucleated hemopoietie cells but is not expressed on
RIDCs. The RIDC population was defined by (10.89.4 +ve) cells minus
(PHMI +ve) cells. Cell numbers arc expressed as cells/mm2 SCM.
When compared with normal renal tissue, there was a significant
increase in both the total interstitial cell population (10.89.4 260
44 vs. 68 2.8 (P < 0.001) and the infiltrating leucoeytes (PHM1 +ve)
162 32 vs. 36 5 (P < 0.01). '[here was a marked increase in the
interstitial dendritie cell population 98 16 vs. 36 5 (P < 0.01),
however the proportion of the total interstitial cells comprised of cells
of dendritic phenotype was the same in the interstitium in normals and
lupus nephritis. Dendritic cells in the renal interstitium therefore
accumulate in propoi'tion to the degree of interstitial leueocytie intiltra-
tion. Whether this is due to proliferation of intrinsic RIDCs or infiltra-
tion by circulating dendritie cells is yet to be determined. Tt is probable
however that these cells, which are potent accessory immune cells in
other sites, play a role in the immunopathogenesis of the interstitial
lesion in human lupus nephritis.
Inhibition of idiotypic anti-glomerular basement membrane antibodies
with hctcrologous anti-idiotypic antibodies using a splenic PFC assay.
J.A. Sovige, C.M. Lockwood, MRC Clinicol immunology Unit, Royol
Post-gmnduote Medicol School, London, United Kingdom. We have
established a direct plaque—forming cell (PFC) assay using spleens
harvested from BALB/c mice immunized with human glomerular base-
ment membrane (HGBM) (50 meg in CPA x 3) in order to detect the
presence of heterologous anti-idiotypie antibodies to aoti-HGBM anti-
bodies. Briefly, 50 j.d of washed spleen cells (l0 mU') were incubated
for I hour at 37°C with 10 jzl 10% RBC coaled with HGBM (using the
CrCI3 method), 10 pA 1:2 guinea pig complement and 10 pA RPM in
Cunningham Chambers. A heterologous auti-idiotypie antibody was
prepared by C. Savage by repeatedly immunizing a NZW rabbit with
affinity—purified human anti-GBM antibody. After extensive absorption
against normal mouse serum, tgG extracts were absorbed and eluted
from a MCA (anti-HGBM) or --MCA column. Ten pA of these
neutralized eluates, with a concentration of 10-2 mg ml were added to
the PFC assay. The eluate from the +MCA columns resulted in
inhibition in five out of five assays (38%) to 88% decrease total number
of plaques, compared with the number seen with eluatcs from —MCA
columns). Eluates were prepared in an identical fashion for IgU extracts
from acute (3) and convalescent sera (3) of patients with anti-GBM
antibody disease. (Anti-GBM antibodies were first removed from the
acute phase IgU). No inhibition was demonstrated when 10 j.d of eluates
(10-2 mg mU') from MCA and —MCA columns were added to the
direct PFC (±2). The inability to demonstrate inhibition by a putative
human anti-idiotypic antibody using this assay system may be because
the concentration of anti-idiotypic antibody was too low to he detected
in this assay, or because of MCA is a cross—reactive idiotype of linuted
distribution in humans.
Serum sickness nephropathy in the rat using cationized albumin. B.F.
Murphy, AfT'. d'Apice, G.J. Becker, P.S. Kincoid—Smith, The Royol
Melboomne Ho.spttol, Melbourne, Austmolio. Kamil and Border have
demonstrated mcsangial as well as capillary loop deposits on in-
munofluorescence (IF) and electron microscopy (EM) in rats injected
with cationic albumin as distinct from rabbits who develop a pure
membranous nephropathy. We have obtained similar but much larger
lesions by increasing the pre-immunization. Sprague—Dawley rats were
pre-immunized with human serum albumin (HSA) in adjuvant using
different regimes which resulted in either high or low titers of precipi-
tating antibodies. Daily intravenous injections of 2 mg of eationized
USA (cHSA) were then commenced. Rats with low titer anti-I-ISA
antibodies prior to i.v. injection developed massive proteinuria five
days after commencement of iv. cHSA. Subepithclial, suhendothelial,
and inesangial deposits of USA, lgG and C3 were seen on IF at five
days and increased over 25 days. At day 25, light microscopy (LM)
revealed scattered subepithelial deposits and early spike formation;
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extensive subepithelial and some subendothelial deposits were seen on
EM. In rats with high titer antibodies, proteinuria did not develop until
10 to 14 days after commencement of i.v. injection. However, by 25
days there were gross confluent subendothelial deposits together with
widespread subepithelial and mesangial deposits clearly visible on LM.
Further groups of rats given 5 mg i.v. cHSA daily showed similar
findings except for earlier development of proteinuna and deposits.
Control rats pre-immunized with adjuvant alone then injected with
cHSA developed no disease.
Antigen identification in glomerulonephritis using monoclonal antibod-
ies. B.F. Murphy, A.J.F. d'Apice, G.J. Becker, P.S. Kincaid—Smith.
Royal Melbourne Hospital, Melbourne, Australia. Monoclonal antibod-
ies have been raised against components of glomerular immune deposits
in experimental and human glomerulonephritis (GN). An accelerated
model of chronic serum sickness in the rat using cationized human
serum albumin (HSA) was employed to obtain renal tissue with
capillary loop and mesangial immune deposits. Lesions ranging from
very early deposits seen only on immunofluorescence to gross deposits
clearly visible on light microscopy were produced. Glomeruli were then
isolated by graded sieving, and Balb C mice were immunized twice in
adjuvant with approximately 4,000 washed whole glomeruli or a prep-
aration of glomerular basement membrane (GBM) obtained by ultra-
sonification. Mice spleens were harvested three days after an intraperi-
toneal boost of GBM and fused with SP2/0 myeloma cells. Colonies
were screened by ELISA at 10 days for mouse immunoglobulin
production and for reactivity against HSA. Anti-HSA monoclonal
antibodies were produced from all technically successful fusions irre-
spective of the amount of deposit in immunizing tissue or whether
whole glomeruli or GBM were used for immunization. Glomeruli from
a human kidney with membranous glomerulonephritis have also been
used for immunization and fusion. Colonies were screened histologi-
cally for antibodies reactive against the GBM deposits in the immuniz-
ing kidney. Eighteen such antibodies have so far been produced. One
has been identified as reactive against C3 and the others are yet to be
characterized.
Identification of circulating immune complex (CIC) constituents by
combined thin gel isoelectric focusing (IEF) and immunoblot analysis.
T.J. Neale, J.C. Muir, B. Drake, Department of Medicine, Wellington
Clinical School of Medicine, Wellington, New Zealand. Assays based
on physicochemical and/or biological properties of CICs allow their
quantitation, but constituent components are rarely identified. We
applied sensitive analytic techniques to precipitated complexes from a
patient with Candida albicans thoracic vertebral osteomyelitis, and
end—stage renal failure due to lupus nephritis. Candida albicans was
present in biopsy material from the vertebral lesion but not in blood
cultures, or in bone after four weeks antifungal therapy. CIC measured
by 2% polyethylene glycol (PEG) precipitation, and Clq and anti-C3
microELISA assays peaked during the illness, falling to background
following antifungal therapy and surgical excision with bone grafting.
Candidal precipitins were measurable three months prior to presenta-
tion and throughout treatment but were undetectable eight weeks
following surgery. Analysis of PEG-precipitated CIC by thin gel IEF
(pH 3.5-10) on polyacrylamide or agarose revealed homology between
two anodal bands and reference Candida mannoprotein antigens (Im-
munomycologics), with approximate molecular weights of 52 to 60 kd.
Nitrocellulose press blots and Western transblots of IEF-separated CIC
probed with specific antisera to mannan, Candida somatic antigens,
Clq and C3 indicated their contribution to the CICs. Blots of Candida
antigens were probed with peak precipitin serum to define the reactivity
of free antibody. These sensitive techniques were applicable to CIC
component identification where the likely origin of antigen was known.
It is intended to extend their use to unknown systems in patients with
glomerulonephritis.
Verapamil (V) slows the progression of experimental chronic renal
failure (CRF). D.C.H. Harris, W.S. Hammond, T.J. Burke, R. W.
Schrier, Department of Medicine, University of Colorado School of
Medicine, Denver, Colorado, USA. V ameliorates ischemic acute renal
failure (ARF) and chronic V administration reduces the magnitude of
uremic nephrocalcinosis (NC) found three weeks after subtotal
nephrectomy (SNX). In the present study, the effect of chronic Von the
progression of renal injury after SNX was examined. V (0.1 zg/g body
wt sc bid) or saline (S, 0.1 ml sc bid) were administered from day 10
after SNX for up to 23 weeks to 10 pairs of rats, which were matched
initially for renal functional impairment and body weight. Rats were
pair fed in metabolic cages and metabolic parameters were measured
every two weeks. Just prior to the uremic death of an S treated rat, both
members of the pair were electively sacrificed. At sacrifice, V rats had
a lower serum creatinine (SCr 0.202 vs. 0.265 mmol/liter, P < 0.05) and
a higher creatinine clearance (CCr 318 vs. 164 zl/min, P < 0.05) than S
treated rats. Proteinuria was similar in the two groups (294 vs. 354
mg/24 hr, NS). Glomerular sclerosis, NC, and total renal damage were
more severe in S treated rats. Renal and myocardial Ca content were
higher in S rats (102.3 and 14.0 nmol/mg dw, respectively) than in V rats
(39.4 and 7.2, P < 0.05). In a second group of rats (N = 22), survival
was studied. Each week from week seven, survival was significantly
better for V rats (P < 0.0025 at week 14). SCr was higher at week 10
(0.149 vs. 0.097 mmol/liter, P < 0.05) in S rats. Mean arterial pressure
measured at least 45 minutes after V or S was not significantly different
between the two groups. Thus, chronic V administration delays the
progression of renal failure, lessens the magnitude of histological
damage and NC, and improves survival in this model of CRF. This
protective effect of V is independent of any antihypertensive effect.
Parameters for the evaluation of renal phosphate (P) handling and of
parathyroid (PT) activity in children. H. Stark, B. Eisenstein, M.
Davidovitz, H. Kaufman, Pediatric Nephrology Unit and Endocrine
Laboratory, Beilinson Medical Center, Israel. Evaluation of renal
handling of P and PT activity in children is hampered by an absence of
normal standards for various parameters in the pediatric age—groups.
Serum PTH (C-terminal), urinary cAMP (UcAMP) and tubular reab-
sorption of P (TP) were determined in 41 healthy children aged one
month to 16 years. TP was measured as P filtered—P excreted (per dl
glomerular filtrate)
= s, — mg/dl.
We prefer this directly measured parameter to the commonly used









1/12—2 5.1 0.9 0.38 0.17 2.5 1.5
2—5 a4.6 0.6 0.30 0.15 2.0 0.7
5—10 4.6 0.6 0.38 0.15 1.7 0.4
10—16 42 0.6 aO.23 0.10 2.2 0.7
Adult values 2.9 0.2 0.44 0.22 3.0 0.8
a Significantly different from preceding value.
Values for children were significantly different from adults. Correlation
was found between TP and cAMP: TP = 5.5 — 0.5 X UCAMP (r = 0.45,P < 0.05), with a scatter of 0.6 mg/dl (± I SD). The absence of
significant correlation between TP and PTH suggests the latter (as
measured here) is not a sensitive parameter of PT activity. The use of
these data to evaluate respective influences of tubular function and of
PT activity is demonstrated in children with various disorders of P
metabolism.
Calcitriol levels in moderate chronic renal failure. B.G. Hutchison,
R.L. Prince, J. Kent, G.N. Kent, R.W. Retallack, Departments of
Renal Medicine, Medicine and Endocrinology and Diabetes, Sir
Charles Gairdner Hospital, Nedlands, 6009, Australia. The role of
calcitriol (1,25D) in calcium (Ca) homeostasis in early chronic renal
failure (CRF) is still controversial. Ca deprivation has been used to
study this area. Six patients with a mean glomerular filtration rate
(GFR) of 43 mI/mm (range 27 to 80) and six age and sex matched normal
subjects with a mean GFR of 122 mI/mm (range 94 to 189) were studied.
Ca deprivation was induced by consumption of a low-Ca diet supple-
mented with oral cellulose phosphate. Samples were collected on two
baseline days (days —4 and 0) and during Ca deprivation which
continued for seven days. 1,25D and immunoreactive parathyroid
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hormone (iPTH) were measured using previously described methodol-
ogy.
iPTH (pmol/liter) I ,25D (pg/mi)





























Baseline —4 0.3 0.1 0.5 0.1
Baseline —0 0.4 0.1 0.5 0.1
Day +2 0.6 0.1 0.7
Day 0.4 0.1 0.8 or
Day +7 0.4 0.1 0.8 or
Results are mean 5EM.
a P < 0.05.
' P < 0.02
Cf Baseline.
iPTH levels were much higher in CRF patients than normals and rose
during the study. Basal I ,25D levels were lower in CRF patients than
normals hut nevertheless rose significantly with Ca deprivation. When
I ,25D levels were corrected for the reduced GFR, there was no
ditference in peak stimulated l,25D between normals and CRF patients.
Throughout the study in CRF patients, plasma phosphate was high
normal and TmP was very low, suggesting relative renal phosphate
retention. Conclusions: (1) in moderate CRF I ,25D is markedly re-
duced. (2) during Ca deprivation, l,25D rises, indicating secretory
reserve. When corrected for GFR, stimulated I ,25D is the same as
normal, despite high PTI-1. (3) The relative resistaoce of l,25D to PIH
stimulation may be related to altered renal phosphate handling. (4) This
study suggests a significant role for t,25D early in the development of
CRF-rclated disturbances of Ca homcostasis.
Renal failure does not impair elimination of morphine. K.L. Lynn, D.
Winter, D.F. Woolner, E.J. Begg, T.J. Frendin, CF. Wright, Deport-
ment of Nephrology, Christcharch Hospital. Departments of
Anaesthetics and Medicine, Chrkstchurch Clinical School, Department
of Chemistry, University of' Canterbury, Christchurch, New Zealand.
Recent studies using radioimmunoassay suggest that the kidney and not
the liver is the main site of opioid metabolism. We have used gas
chromatography—mass spectrometry (GC-MS) to assess the elimination
of morphine and its glucuronides, after IM papaveretum (--50% anhy-
drous morphine), in four men (one ancphric), aged 34 to 60 years, on
hemodialysis and three normal men, aged 34 to 41 years. Each patient
had a forearm fistula, normal liver function tests and was studied on a
non-dialysis day. Papaveretum (0.25 mg/kg body wt) was injected in the
deltoid muscle (listula arm in patients). Venous blood was obtained
from the contralateral arm at intervals up to 24 hours. The





Healthy Mean 0.09 2.17
volunteers 5EM 0.03 0.13













Healthy 134.62 1.28 4.01
volunteers 14,32 0.14 tl.43





The patients with renal failure had significantly shorter t'A (abs) and t'A
(chm) for morphine and eliminated the glucuronidcs slowly, these
results suggest that renal failure does not impair the elimination of
morphine.
Anti-glomerular basement membrane glomerulonephritis (AGBMGN)
associated with membranous transformation (MT): A report of five eases.
iF. Dowling. B.U. Ihie, G. Becker. SR. Holdsu'orth. D.C. Mathews,
P. Kincaid—Smith, Departments of Anatomical Pathology and
Nephrologv, Royal Melbourne Jiosisital arid Department of Jtiedicine,
Prince Henry's Hospital, Melbourne, Australia. Of a group of 22
patients with confirmed AGBMGN. tivc were noted to develop MT in
association with ditl'use crescentic glomerulonephritis. A summary
















l/MH 20/F 6/80 Macroscopic + + + 0.48 0.10
2/ST 19/F 12/81 Macroscopic 0.4 1.3 0.38
3/KL 47/M 11/83 Macroscopic —" 1.43
4/GD 18/M 10/84 Macroscopic +++ 0.81 0.19
5/KG 17/F 12/84 Macroscopic 6.5 0.12 0.09
O No urine obtained for estimation.
At presentation.
2 Current (Oct, 85).
All patients showed the presence uf AGBM antibodies on radio-
immunoassay. Patient I, MH, subsequently was found to have an
anti-nuclear factor and a raised DNA binding. Only one patient, KG,
had haemaptysis. All patients received therapy with a combination of
cyclophosphamide and prednisulone with anticoagulation and plasma-
pheresis. Four patients responded well to these measures with two (MH
and KG) having a serum creatinine currently within normal limits and
two (GD and ST) having persistent impairment of renal function.
Patient 3. KL. progressed rapidly to end—stage renal failure, requiring
transplantation; grat't function isat present excellent. All patients
showed diffuse crescentic UN with at least 85% crescents on initial
biopsy. In three, (ST, KL and KG) MT was noted on the first biopsy
and was diffusely developed in KE. and KG and focal in ST. Focal MT
was found in follow—up biopsies of MH and GD. The distribution of MT
has remained similar in further follow—up biopsies of MU, ST. (iD and
K'f. A recent transplant biopsy of KL revealed mild interstitial rejec-
tion and segmental glomcrular nccrotizing lesions; radioimmunoassay
for AGBM antibodies was negative. Varying degrees of proteinuria
persist in the patients not transplanted. Despite this, the outcome in this
group of patients appears to he governed more by the activity of the
AGBM component of the renal lesion than the MT.
The hypertensive effect of eyelosporine A in sheep. E.H. Mills, J.P.
Coghlan, D.A . Denton, .1G. McDougall, C.D . Spence. .1.1. Treshntn,
BA. Sc'oggins, J.A . Wlotworth, Howard Florev Institute of Fs'perimei—
tal Physiology & Medicine, a rid Royal Melbourne Hospital. University
of'Melbourne, Parki'ille, 3052, Australia. The immunosuppressive drug
cyclosporine A (CYA) has been reported ta be associated with hyper-
tension in renal and cardiac ti'ansptantcd subjects. 'I'his study examines
the haemadynamic, renal and hormonal effects of CYA in sheep. Six
conscious sheep (body wt 35 ta 45 kg) were infused i.v. 12 mg/kg/day
CYA for live days. Mean arterial pressure (MAP) was increased from
days Ito 5, 73 I mm Hg control to 90 4 mm Hg on day 5 of CYA
infusion (P <0.001). Heart rate increased an days 1,2,3 and 5 nfCYA,
58 3 heats/nun control to 75 1 5 heats/mm day 5 (P < 0.01). Cardiac
output did not change. but calculated total peripheral resistance was
elevated an days I, 3 and 4, 16 I mm Hg mm/liter control to 21 2
nun Hg mm/titer day 4 (P < 0.00 It. Stroke volume decreased, 86 7
mI/beat control to 68 8 mI/beat on day 5 (P C 0.001). There was no
change in plasma (Na], hut there was a decrease in plasma [K], 4.3 1
0.1 mmol/liter control and 4.1) 0.1 mmol/Iiter an clay S (P < 0.001).
'l'here was afallin water intake on days 3,4 and 5.2.02 0.12 liter/day
control and 1.65 0.28 liter/day 5 (P -C t).05). Urine volume did not
change with CYA infusion. Urinary Na excretion decreased an days 2
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to 5 of infusion. Plasma renin concentration was unchanged by CYA.
One of the six animals developed reversible oliguria over the first two
days of CYA infusion, and the infusion was terminated. CYA did not
change GFR but effective renal plasma flow increased 429 18 to 559
44 ml/min on day 5 (P < 0.05). There was no change in filtration
fraction, renal vascular resistance, renal blood flow or body weight.
These results indicate that CYA reproducibly produces significant
hypertension, even in the absence of a reduction in renal function. The
resistance mediated hypertension is not simply a consequence of
nephrotoxicity.
Atrial natriuretic peptide (ANP) release with volume changes in chronic
renal failure. R.J. Walker, C.P. Swainson, Department of Nephrology,
Christchurch Hospital, Christchurch, New Zealand. The effect of ECF
volume changes on the release of ANP was studied in nine patients (six
male, three female) on chronic hemodialysis (no antihypertensive
medication) 48 hours after their last dialysis. Patients with ischemic
heart disease or diabetes mellitus were excluded. Ultrafiltration was
adjusted so that body weight fell 4% over two hours, then saline was
steadily infused until weight returned to the starting point over two
hours, plus a further 30 minute infusion. Blood was drawn at 30 minute
intervals for ANP, aldosterone, electrolytes and creatinine, and blood
pressure, pulse and weight were recorded. The initial AMP ranged from
30 to 112 pmol/liter. During volume reduction ANP fell by a mean of
28.8% (SD 13.7), but during volume expansion there was a much larger
rise in ANP, mean 99% (SD 69). There was no significant change in
plasma potassium, creatinine, or aldosterone concentrations. During
volume expansion ANP release was rapid and quantitatively much
larger than the fall from baseline seen with volume reduction. These
results confirm that ANP is released in response to acute volume
expansion, which may be mediated through stretch receptors in the
atria.
Effect of atrial natriuretic factor on vasopressin release. K. Ogawa,
C.!. Johnston, Monash University Department of Medicine, Prince
Henry's Hospital, St. Kilda Road, Melbourne, 3004, Australia. Atrial
natriuretic factor (ANF) is a circulating peptide hormone stored in
specific atrial granules. The biological actions of ANF (natriuresis,
diuresis, vasodilation) are opposite to those of arginine—vasopressin(AVP). This study was designed to investigate the effects of
intracerebroventricular (ICY) or intravenous (i.v.) injection of ANF (rat
a atrial natriuretic polypeptide, Peninsula Lab, 28AA) on plasma AVP,
plasma renin activity (PRA), blood pressure (BP), and pulse rate (PR) in
conscious rats. Studies were performed in conscious unrestrained rats
with chronic indwelling lateral ventricular cannulae and venous and
arterial catheters. ANF (0.3 nmol/kg ICY, 0.1 nmol/kg i.v. or 2.5
nmol/kg i.v.) was injected into 24 hour water—deprived or normal-
ly—hydrated Long—Evans rats. Plasma AVP and PRA were measured by
radioimmunoassay. No changes were observed in plasma AVP and
PRA following ANF ICy injection. No changes were found in BP and
PR after four different doses of ICY ANF injection (0.01 to 0.3
nmol/kg). No significant changes were observed in plasma AVP after
i.v. ANF injection (0.1 or 2.5 nmol/kg) either in hydrated or dehydrated
rats. However rehydration caused a prompt fall in AVP levels to normal
within 30 minutes. The lower dose of ANF was not associated with any
haemodynamic effect, but a dose related fall in blood pressure was seen
with the high dose of ANF. ANF administration (2.5 nmol/kg i.v.)
decreased PRA in both hydrated and dehydrated rats. We conclude that
neither iv. nor ICV ANF administration affect AVP release in con-
scious rats,
Enhancement of the renal but not hemodynamic effects of atrial
natriuretic peptide in conscious sheep. D.G. Parkes, N.A. Yates, J.P.
Coghlan, D.A. Denton, J.G. McDougall, BA. Scoggins, Howard
Florey Institute, University of Melbourne, Parkville, Victoria 3052,
Australia. Atrial natriuretic peptide (ANP) has diuretic, natriuretic and
vasodepressor activity in rats, dogs, sheep, and man. In normal sheep
the dose threshold for hemodynamic effects is less than that for effects
on the kidney. To examine whether volume status influences the
physiological responses to ANP the peptide has been infused in
isovolemic, hypervolemic, and ACTH hypertensive conscious sheep.
ANP (1-28) was infused intravenously at 100 pg/hr for 60 minutes into:
(1) normotensive isovolemic sheep; (2) sheep in which blood volume
had been expanded 30% with dextran; and (3) sheep with ACTH
hypertension (5 sg/kg/day for five days) and in whom plasma volume is
increased. The renal effects were also examined in sodium (Na)
depleted sheep (48 hr uncompensated parotid salivary loss). In
isovolemic sheep, ANP reduced blood pressure (MAP) by 3 2 mm Hg
(P < 0.05) due to a fall in cardiac output. Neither volume expansion nor
ACTH treatment produced a significant change in the effects on MAP.
In contrast, in volume—expanded sheep ANP increased urine flow by
8.9 2.3 mI/mm (P < 0.01) compared with 0.3 0.1 mI/mm in
isovolemic animals. Urinary Na excretion increased by 688 130
smol/min volume expanded compared with 58 10 smol/min
isovolemic. A similar enhancement of the renal effects was seen in
ACTH treated sheep. In Na depleted sheep the renal effects of ANP
were reduced. In summary, these studies show that the renal response
to ANP is modulated by the volume status of the animal.
Mechanism of Cyclosporine A stimulation of renal cortical slice renin
secretion. G. Duggin, V. Lazarro, C. Baxter, B. Hall, J. Horvath, D.
Tiller, Department of Renal Medicine, Royal Prince Albert Hospital,
Camperdown, Australia. The intrarenal renin angiotensin system is
thought to play a major role in the intrarenal control of glomerular
filtration rate (GFR). CSA treated patients show a significant drop in
GFR and this decrease is usually rapidly reversed on cessation of the
drug, suggesting that CSA is directly or indirectly affecting the intrare-
nal control fo GFR. Studies were undertaken in Firth Wistar rat renal
cortical slices. The stimulation of renin release by CSA was studied by
incubating renal cortical slices with the drug and determining the renin
activity in the incubation media. CSA 8 x 10-6 mol stimulated renin
secretion significantly above control, although not to the same extent as
Isoproterenol. Angiotensin II and 60 mmol KC1, which inhibited renin
release, were not overcome by CSA. CSA stimulated renin release was
blocked by the beta adrenoreceptor antagonists Timolol and Atenolol.
As CSA is not a beta agonist, this would suggest that CSA indirectly
affects the beta adrenoreceptors, perhaps by the local release of
noradrenaline.
Renal functional effects of ACTH and hydrocortisone administration in
man. J.A. Whitworth, J.M.C. Connell, A.F. Lever, R. Fraser, Depart-
ment of Nephrology, Royal Melbourne Hospital, Melbourne, Australia,
and MRC Blood Pressure Unit, Glasgow, Scotland, United Kingdom.
Administration of ACTH or glucocorticoid hormones has been vari-
ously reported to increase renal plasma flow (ERPF) and/or glomerular
filtration rate (GFR) in a variety of species. The present study examines
the effects on renal function of ACTH (0.5 mg I/M 12 hourly) or
hydrocortisone (50 mg 0 6 hourly) in six normal men. Subjects were
maintained on 150 mol/day Na and 70 mmol/day K diet for II days.
After four control days, ACTH or hydrocortisone was given for five
days. Urine volume, Na, and K excretion and creatinine clearance were
measured daily. Renal function tests were performed prior to and on the
final day of treatment. GFR was measured by inulin clearance and
ERPF and PAH clearance, before and after infusion of angiotensin II at
2, 4 and 8 ng/kg/min. ACTH produced urinary sodium retention (control
135 8, ACTH 36 12 mmol/day, P < 0.001) and an increase in
urinary potassium excretion (control 67 3, ACTH 90 4 mmol/day,
P < 0.01) but no change in urine volume or creatinine clearance. lnulin
clearance increased from 142 8 to 200 16 mI/mm (P < 0.01) but
there was no change iN ERPF. Filtration fraction rose from 18.7 1.1
to 26.1 0.9% (P < 0.001). Angiotensin II produced dose dependent
falls in ERPF both before and after ACTH treatment. GFR fell at high
dose only and filtration fraction increased. Hydrocortisone produced
initial urine sodium retention only. Urine volume and creatinine clear-
ance were unchanged. Inulin clearance rose from 141 II to 160 13
mI/mm (P < 0.001). Renal plasma flow was unchanged and filtration
fraction fell. Angiotensin infusion produced results similar to those seen
in the ACTH study. Thus both ACTH and hydrocortisone produced
urinary sodium retention and increases in inulin clearance and filtration
fraction. Renal plasma flow and creatinine clearance were unchanged.
The latter, thus, is an unreliable measure of GFR during steroid
administration. Angiotension II administration produced substantial
falls in renal plasma flow, but a rise in filtration fraction tended to
maintain GFR.
Comparison of calcitonin and parathyroid hormone on renal calcium
and magnesium transport in the rat. S.L. Carney, University of
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Newcastle, Newcastle, N.S. W., Australia. There is now good evidence
that calcitonin (CT) can facilitate renal calcium and magnesium reab-
sorption within the thick ascending limb of DenIes loop like parathy-
mid hormone (PTH). While the cellular mechanism of action is unclear,
CT and PTI-1 dependent adenylate cyclase activities within the mam-
malian distal nephron are also similar and concurrent administration nf
CT and PTH does not produce an additive effect on cyclic AMP
prodnction. This suggests the presence of a single pool of hor-
mone—dependent cyclase activity which responds equally to both CT
and PTII. Clearance studies were performed on anesthetized
thyroparathyroidectomized rats infused with a calcium Ringer solution
to see if these biochemical observations could be reproduced at a
biological level. PTII (2.5UIlOOg) reduced the fractional excretion of
calcium from 9.8 0.6 to 5.1 0.6% (P ci t).0l) and CT (0.l5U/lOOg)
also produced a comparable fall in the excretion of calcium (4.1
0.6%). Administration of both CT and PTH was associated with a
fractional calcium excretion of 3.0 c 0.8% which was significantly less
than that observed with PTH alone (P < 0.05). Since there is evidence
that hypercalcemia associated with PTH administration directly re-
duces renal calcium reabsorption suhosaximal concentrations of PTH
and CT were simultaneously given to a further group of rats and the
fractional excretion of calcium was 3.6 0.9%. Magnesium data were
similar to that of calcium. These results combined with earlier in vitro
data suggest that PTH and CT act upon the same renal transport site to
facilitate calcium and magnesium transport.
Physiological role of angtotensin-I1 in the control of baroreflex sensi-
tivity. MG. Garner, A Phippard, P.J. Fletcher, J. Maclean, G. Doggin,
J. Horvath, 1). Tiller, Hypertension and Cardiology floPs, Royal
Prince Alfred Hospital, Catnperdown, Australia. Studies of the effect of
angioteosin II (Alt) on baroreflex function have failed to determine its
physiological significance. Species differences, variable study methods
and failure to control for other factors such as plasma volume (PV),
sodium (Na) status, and direct AtI effect on arterial pressure (BP) have
all contributed to canflicting results. tn this study, baroreflex function
was examined in four adult male baboons (Papio hamadryas) with
chronic arterial and venous catheters, during manipulation of the renin
aogiotcusin system. Baroretlex sensitivity was assessed by dupticatc
determinations of the slope between heart rate (BR) and BP, during
paired intravenous injections of phenylephrine (P1-IF) and glyceryl
trinitrate (OTN). On high salt diet (100 mmol Na/day) slope was
assessed before and during graded All infusion (10 & 20 ug/kg/min)
which raised BP by 20 tO and 32 12 mm Hg. To separate the direct
effects of Alt from indirect effects due to the rise in BP, assessment of
slope during All infusion was repeated on a separate day with simul-
taneous infusion of GTN to prevent the rise in BP. On low salt diet (5
mmol Na/day) slope was assessed before and after captoprit (1 mg/kg &
5 mg/kg intravenously) which produced graded suppression of endoge-
nous All and lowered BP by 5 4 and 10 6 mm Hg. This protocol
was repeated on a separate day with simultaneous infusion of PHE to
prevent the fall in BP. Changing sodium intake had no effect on plasma
volume, basal BP, HR or slope. All infusion caused a significant
decrease in slope (P ci 0.01) which was still apparent after control of
acute hypertension. Att antagonism caused a smaficr but still significant
increase in slope (P < 0.05), still apparent after prevention of acute
hypotension. The data suggests that physiological variations in All
levels have a small effect on sensitivity of the baroreflex arc indepen-
dent of its effects on blood pressure.
Somatostatin may also modulate collecting duct water permeability in
the absence of arginine vasopressin. C. Ray, ST. Carnev, A.H.B.
Gillies, Facolty of Medicine, University of Newcastle, Newcastle,
Australia. Recent in vitro experiments in our laboratory supported
earlier evidence that somatustatin inhibits the antidiuretic action of
arginiue vasoprcssin in the mammalian collecting duct. At the same
time somatostatin inhibited basal water permeability (3.18 0.14
compared with 3.75 0,09 pm/see; P ci 0.05) at concentrations of
109M but not at higher concentrations (tO 107M). Therefore clear-
ance studies in water diuretic anesthetized wistar rats were performed.
Sumatostatin (30 .sg holus and 60 j,sg/hr) increased urine volume from
132 tO to 163 8 and 160 II j.d/min (P < 0.01) without altering
urinary solute excretion. However, increasing the somatostatin concen-
tration (150 sg bolus and 600 pg/hr) did not significantly alter urine flow
or solute excretion when compared to control values. Gtomerular
filtration rate, urinary electrolyte excretion, and papillary solute con-
centrations were unaltered by somatostatiu. In vivo and in vitro
evidence that somatostatin can alter both basal and arginine vasopres-
sin stimulated water permeability requires further work to evaluate its
significance in the control of body water metabolism.
Circulating inhibitors of Na-K-ATPase respond to changes in osmolal-
ity rather than volume. R.M. Wellard, W.R. Adam, Renal Unit,
Repatriation General Hospital, W. heidelberg 3081 Victoria, Australia.
The search fur natriuretic factors (circulating inhibitors of Na-K-
ATPase being a contender for natriuretic factor) has centered around a
physiological role to prevent extraccllular volume overload following
excess sodium ingestion and a pathophysiotogical rote in hypertension.
However water deprivation is a more likely homcustatic insult than
sodium excess and is associated with an increased sodium excretion,
presumabty a protective mechanism against hypernatremia (and/or
hyperosmolality). In this study we look at the effects of plasma from
control, dehydrated, rehydrated, low and high sodium diet rats on
Na-K-ATPase and rubidium (Rb) transport in guinea pig renal tubules.
Na-K-ATPase Rb transport
Group % of control % of control
Plasma
Na mmol/liter
A. (i) Control tOO 17 (16) tOO 14 (8) 126 2.2 (16)
(ii) Dehydrated 86 12 )l6 76 18 (7)' 130 1.4 (16Y'
(iii) Rehydrated 100 t 15 (16) 103 16 (8) 122 2.1 (16)
ANOVA P <tl.025 <0.01 <0.05
a (P < 0.01) compared to controls
B. (i) Control 100 8(8) 100 14(5) 128 1.6 (8)
(ii) Low Na 93 18 (8) 106 18 (5) 130 0.8 (8)
(iii) High Na 101 22(7) 113 8 (5) 128 2.1 (7)
ANOVA P >0.05 >0.05 >0.05
Plasma from dehydrated rats was associated with a rise in plasma
sodium, and an inhibitory effect un tubular Na-K-ATPase and rubidium
transport (A.). By contrast, a high sodium diet had no effect on
Na-K-ATPase or rubidium transport (H.). These results suggest that in
terms of common homeostatic insults, the release of circulating inhib-
itors of Na-K-ATPase is more responsive to water deprivation than
sodium largcssc.
Acute filtration failure induced by p-aminophenol in rats is not depen-
dent upon activation of tubulo-glomerular feedback. P.J. Harris, MA.
Henry, L.L. Walker, S.L. Skinner, J.D. Tange, Departments of Phys-
iology and Pathology, University of Melboarne, Melbourne, Australia.
Severe reduction of glomerular filtration rate is an essential initial
feature of the acute renal failure that accompanies tubular necrosis.
Obstructive casts within the tubule or the activation of tubulo-glumer-
ular feedback in response to reduced proximal reabsurptive activity and
consequent increased solute delivery to the distal tubule have been
proposed as factors contributing to the low filtration rate. 'I'he p-
aminophenol model in rats displays decreased glomerular filtration and
a parallel increase in proximal and distat tubule hydrostatic pressure,
but with little change in urine flow. 'fhis tiltration failure occurs without
evidence of cast formation. In further studies using this model, tubular
fluid was collected under free—flow conditions from proximal or distal
tubules in two groups of animals before and at intervals up to 180
minutes after single iv. injections of p-aminophenol (300 mg/kg body
wt). Proximal tubule pressures were measured prior to fluid collections.























Proximal tubule pressure more than doubled in both groups hut with no
significant changes in proximal or distal flow rates under free—flow
conditions. Thus, glumerular filtration is reduced in this model as a
Abstracts 623
result of the increased tubular pressure rather than as a consequence of
afferent arteriolar constriction. This conclusion is supported by the
observation that renal blood flow is maintained while filtration rate falls
and provides no evidence for activation of tubulo-glomerular feedback.
Prostaglandins and vasodepressor phsopholipids in the reversal of renal
clip hypertension in the rat. H.M. McGowan, R. Vandongen, J.P.
Codde, K.D. Croft, University Department of Medicine, Royal Perth
Hospital, Perth, 6000, Australia. Previous studies have implicated
vasodilatory PGs in the reversal of hypertension following unclipping
the one—kidney, one—clip (IK,IC) hypertensive rat. The capacity of
aorta to synthesize PGI2 was compared in clipped (Group A, N = 9),
unclipped (Group B, N = 8), and (Group D, N = 9), and sham—un-
clipped (Group C, N = 9) lK,1C hypertensive rats. The opportunity
was taken also to examine the possible involvement of PAF, a potent
renal antihypertensive phospholipid, in the reversal of renal clip hyper-
tension. This was assessed by bioassay of the precursor lyso-PAF in
Group C & D, using '4C-serotonin labelled platelets, following acetyla-
tion in vitro. Hypertensive rats (systolic BP > 180 mm Hg) were fed a
linoleic acid supplemented diet for four weeks to enhance PG produc-
tion to amplify the effects of unclipping on PG synthesis. After
measuring BP, Group A was killed immediately whereas Group C was
sham—unclipped, and Group B & D unclipped before killing 24 hours
later. Blood was drawn for measurement of lyso-PAF and the aorta
removed for determination of 6-keto PGF1,,, the hydrolysis product of
PGI2. BP fell in the unclipped rats (Group B & D), but did not change
in the sham—unclipped rats (Group C). Aortic 6-keto PGF1,, was
increased in the unclipped groups (Group B, 15.4 2.4 ng/mg; Group
D, 10.8 2 ng/mg) (mean sEaT) compared with Group A (7.7 I
ng/mg) and Group C (7.1 I ng/mg) (H = 13.74, P < 0.01). Lyso-PAF
was also significantly increased in the unclipped (Group D, 2.62 26
zg/ml) versus the sham—unclipped (2.11 0.23 g/ml) group (P < 0.05).
These findings suggest enhanced phospholipase A2 activity in the
unclipped rat, increasing synthesis of aortic PGI2 and PAF. These may
be involved in the reversal of 1K, IC hypertension.
The effect of blood pressure and dietary fat on prostaglandin synthesis
in 1-kidney, 1-clip Goldblatt rats. J.P. Codde, H.M. McGowan, R.
Vandongen, L.J. Beilin, University Department of Medicine, Royal
Perth Hospital, Perth, 6000, Australia. It has been proposed that
vasodilator prostaglandins (PG) play an important role in the regulation
of blood pressure (BP). This study examines the effects of diets
enriched with fatty acids on PG synthesis and blood pressure in
1-kidney, 1-clip Goldblatt rats. Rats with BP> 180 mm Hg within eight
weeks of nephrectomy and renal artery stenosis were paired by weight
and blood pressure, and placed on either a prostanoid 'enhancing'
safflower oil (77% LA) or prostanoid 'inhibitory' cod liver oil/linseed oil
mix (6.7% EPA, 4.8% LNA, 4.7% LA) enriched (10% wt/wt) diet for
four weeks. At completion of the dietary period, a 24 hour urine sample
was collected and then blood, aorta, and remaining kidney removed for
lipid and PG analysis. Animals with BP < 150 were also paired and
followed the same dietary and experimental protocol. Comparison
between the two BP groups revealed that on both dietary regimens
hyptertensive rats produced significantly more aortic 6-keto-PGF1,, and
serum TXB2. Rats on the EPA/LNA enriched diet had significantly
impaired ability to generate serum TXB2 (36%), aortic 6-keto-PGF1,
(65%), renal homogenate 6-keto-PGF1,, (64%) and PGE2, and urinary
6-keto-PGF1,, excretion (52%) compared to LA enriched rats. Despite
these differences in PG synthesizing capacity, dietary linoleic acid did
not protect against nor did EPA/LNA exacerbate established I-kidney,
I-clip hypertension. However the enhanced synthesis in vitro of aortic
PGI2 and blood TXB2 in hypertensive rats appears to be an adaptive or
pathological response to the high blood pressure.
Comparison of nicardipine and propranolol, added to hydrochlo-
rothiazide, in the treatment of hypertension. R.N. Wyndhain, J. Show,
R. Gordon, R.V. Jackson, G. Macdonald, G. Stokes, Repatriation
Hospitals, Sydney and Brisbane, Prince Henry Hospital, and Royal
North Shore Hospital, Sydney, Australia. Nicardipine is a calcium
channel blocker. We compared nicardipine, 30 mg tds (N) with pro-
pranolol, 40 mg tds (P) given to patients with moderate to severe
hypertension treated with hydrochlorothiazide 50 mg daily (H). The
study was a 14 week double—blind randomized crossover design. All
patients took (H) for 14 weeks. During the first four weeks they also
took a placebo. This was followed by two 4 week periods of active
treatment separated by a two week washout. Twenty—four patients
completed the study. Their ages ranged from 28 to 75 years and 20 were
male. Results at the end of each four week period (mean SCM)
H+
Placebo H + N H + P
Supine BP, mmHg
Systolic 159.1 4.0 141.8 3.1 140.5 3.8
Diastolic 102.3 1.6 87.4 2.6 86.0 2.0
Standard BP, mmHg
Systolic 149.4 3.9 135.9 4.1 132.3 3.4
Diastolic 102.8 1.4 91.3 2.6 89.4 1.7
Pulse rate/mm
Supine 77.9 1.9 83.1 2.0 67.0 1.8
Standing 83.2 2.5 89.0 2.4 67.9 1.6
N and P had similar effects on blood pressure. However, P significantly
reduced pulse rate compared to N (P < 0.01). Side effects were
common; 23 patients reported 121 adverse effects: 48 mild, 50 moder-
ate, and 23 severe. Of these 69 were ascribed to treatment: 10 to H +
placebo, 32 to H + N and 17 to H + P. Nicardipine is as effective as
propranolol when given with hydrochlorothiazide for moderate to
severe hypertension, but is associated with more side effects.
An open study of enalapril in the treatment of hypertension. R.N.
Wyndharn, M.L. Marel, J.R. Lawrence, J. Shaw, Repairiation General
Hospital, Sydney, Australia. Enalapril (E) is a new angiotensin con-
verting enzyme inhibitor. We conducted an open, dose—finding study of
E combined with hydrochlorothiazide (H) in patients with hyperten-
sion, supine diastolic BP (SDP) 95 to 120 mm Hg after two weeks on no
treatment. All patients entered were started on E 10 mg/day and were
reviewed fortnightly. If SDP had not fallen below 90 mm Hg, there was
a stepwise increase of E by 10 mg daily to 40 mg daily and introduction
of H 25 mg, then 50 mg per day. If SDP was still above 90 mm Hg. a
third agent was added. Twenty patients were enrolled and 15 completed
the study. Their ages ranged from 26 to 82 years and 14 were male. The
doses of drug employed were (mean sn): E 26.7 8.2 mg/day, H 23.3
17.5 mg/day. Two patients required a third agent, I Verapamil 40 mg




Supine BP (mm Hg)
Systolic 178.7 5.4 161.7 7.0 142.7 3.9
Diastolic 104.9 2.2 96.2 3.0 83.3 1.9
Standing BP (mm Hg)
Systolic 171.0 5.9 159.9 6.0 138.8 2.8
Diastolic 109.3 2.0 100.6 2.7 88.3 2.0
Of the 20 patients enrolled, 15 reported a total of 26 side effects, of
which 20 were thought to be due to therapy. Enalapril is an effective
antihypertensive agent when used in combination with hydrochloro-
thiazide. It has a similar side effect profile to other agents.
Proteinuria of diabetes mellitus (DM) is prevented by phosphate
depletion (PD). D.C.H. Harris, A.C. Alfrey, R.W. Schrier, Department
of Medicine, University of Colorado School of Medicine, Denver,
Colorado, USA. PD reduces the proteinuria and delays the progression
of renal dysfunction in rats with nephrotoxic serum nephritis and partial
nephrectomy. In the present study, the effect of PD on the proteinuria
of DM was examined in Sprague—Dawley rats given streptozotocin (30
to 50mg/kg iv.) one week after right nephrectomy. One week later, rats
were paired according to body weight, renal function and severity of
DM. Rats were pair fed a normal rat diet, with (PD) or without (PR) the
phosphate binder dihydroxyaluminum acetoacetate (DHAAA IS g%).
Blood glucose (BGC) was measured twice weekly, body weight weekly,
and mean arterial pressure (MAP) and other metabolic parameters
every two weeks. PD rats had lower serum (1.39 vs. 2.18 mmol/liter,
week Il, P <0.001) and urine (0.19 vs. 6.57 mmol/24 hr. week 11, P <
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0.001) phosphate than PR rats. Serum Ca (2.79 vs. 2.3K mmol/liter,
week 11, P <0.005) and urine Ca (9.33 vs. 3.83 rnmol/24 hr, week 11,
P < 0.00!) were higher in PD than PR rats. At three months, there was
no significant difference between the two groups (PD vs. PR) in body
weight (298 vs. 302 g), kidney weight (2.26 vs. 2.24 g), MAP (86.7 vs.
86.4mm Hg asleep), urine output (103 vs. 109 ml/24 hr), BGC (20.8 vs.
21.1 mmol/liter), insulin requirements (10.4 vs. 10.9 U/week), serum
creatinine (0.070 vs. 0.068 mmol/liter), creatinine clearance (3.66 vs.
3.77 mI/mm/kg body wt) or serum albumin (30.! vs. 29.3 g/!iter).
However, from week 3, proteinuria was. .significantly lower in Pt) rats;
at three months 20.3 (PD) vs. 77.4 mg/24 hr (PR) (P <
.001). PD alooe,
therefore, reduces the magnitude of proteinuria early in DM and
remains protective for at least three months. This protective effect of
PD is independent of other factors such as protein intake, serum
albumin, severity of DM, MAP, and renal function.
Idiopathic membratsous glomerulonephritis: 25 years experience with
144 cases. B.F. Murphy, K.F. Fairley, P.S. Kincaid—Smith, The Royal
Melbourne Hospital, Melbourne, Australia. Clinical details of 144
patients (80 male, 64 female) with idiopathic membranous glomerulo-
nephritis were reviewed. Median age at presentation was 37 (males 43,
females 3!, range 13 to 79). Duration of follow up was Ito 280 months
(median 51). Forty—five percent and 25% were followed for more than
five and 10 years. Principal presenting symptom was edema (56%) and
54% (70% of males, 39% of females) had proteinuria >3.5 g/day.
Median s. albumin was 26 g/liter and median p. creatiniuc was 90
mol/liter (>120 jzmol/liter in 18%). Microscopic hematuria was pres-
ent in 32% and diastolic BP > 11(1 mm Hg in 24%. Renal venograms in
24 patients demonstrated thrombosis in 12. Associated diseases in-
cluded: malignancy (3), sarcoidosis (2), Guillain—Barre syndrome (2),
and reflux nephropathy (2). Forty—three percent of patients were
treated at some stage with Cyclophosphamide, Dipyridamole and
Warfarin. At conclusion of follow—up, 50% of patients were alive with
normal renal function, eight patients (6%) (one female, seven males)
had developed end—stage renal failure, 19 (13%) had impaired renal
functioo, 15 (10%) had died from non-rena! causes, and 30 (12%) were
lost to follow—up. Thirty—eight percent of initially nephrotie patients
remained nephrotic. Renal survival was 95% and 93% at five and 10
years; patient and renal survival was 89% and 82%. The 28 patients who
suffered deterioratioo in renal function were 22 male and six female (P
< 0.05) and had significantly lower median s. albumin, high median
urinary protein and high median p. creatinine than the other patients at
presentation. Median predicted (or actual) time for devclopmcot of
ESRF in the 21 patients with progressive deterioration was 7.3 years.
Outcome of patients with Hcnoch SchUnlelu uephritis. R.J. Walker,
R.R. Bailey, K.L. Lynn, C.P. Swainson, Department of Nephrology,
Christchurch Hospital, Christchurch, Australia. Glomerulonephritis(UN) is the main determinant of mortality in the Henoch Schonlein
syndrome. Renal involvement occurs in 28 to 90% of those with the
syndrome. Seveoteeo patients (10 males) with the Henoch Schbnlein
syndrome and UN who had a renal biopsy between 1 June 1973 and 31
May 1985 were studied prospectively. The patients were aged from 7 to
42 years (mean 20.4). Indications for renal biopsy were microscopic
hematuria (six), macroscopic hematoria (six), acute nephritic syndrome
(four), and uephrotic syndrome (one). The initial biopsy (ISKDC
Classification) showed minimal change (four), mesangial proliferative
UN (five), focal or diffuse proliferative ON with <50% crescents (six),
diffuse proliferative UN with >50% crescents (one), and proliferative
UN (one). lmmuuofluorcscence for mesangial IgA was positive and
electron microscopy showed characteristic electron dense deposits in
all biopsies. Follow—up was from eight months to 9.5 years (median 41
months). No patients were treated with steroids or immunosuppressive
agents. Hypertension was treated aggressively. Thirteen patients were
alive with normat renal function, three reached end—stage renal failure
and one was last to follow—up. The five year cumulative renal survival
rate was 90%. This was similar to other reports. A poorer prognosis was
associated with a clinical presentation with either the acute nephritic or
nephrntic syndrome and with crescent formation. Regular assessment
for a minimum of five years is recommended for patients with Hcuoch
Schonlein UN.
Adult Hcnoch—SchUulein Nephritis A retrospective review. R.J. Faull,
D. Shaw, I. Aarons, A.J. Woodroffi?, AR. Clarkson, Renal Unit, Royal
Adelaide Ho.cpital, Adelatde, Australia. Twenty-seven patients with
Henoch—Schonlein Purpura had renal biopsies at the Royal Adelaide
Hospital from June 1975 to September 1985. Details of initial presenta-
tion and fallow—up were recorded, including severity of histological
lesions of initial renal biopsies. Average follow—up was 28 months. All
patients had microscopic hematuria at presentation. 26 had the charac-
teristic purpuric rash, and 25 had proteinuria. At follow—tip, four
patients had died as a direct result of the disease and one was on chronic
hemodialysis. Nineteen out of 25 patients followed had persistent
detectable abnormality (hypertension, proteinuria and/or elevated
plasma creatiuinc). Of these 25 patients, 10 presented in acute renal
failure, and overall these had a poor outcome. Initial normal serum
creatinine usually heralded few or no later abnormalities. Initial degree
of prnteinuria was unreliable as a prognostic marker. The glomerular
lesions were rated on a scale of 1+ to 3+ for severity of histological
lesions; the mare severe had a correspondingly worse outlook, The
presence of greater than 20% crescents on renal biopsy predicted poor
outcome; however, lack of or small numbers of crescents was an
unreliable indicator of favorable outcome. Treatment with plasmapher-
esis appeared to give a good response in the short term with four
severely involved patients; however, one patient died and another
eventually required chronic hemodialysis. Patients treated with high
dose steroids generally had a poor outcome, probably reflecting their
severe initial disease.
Hemodynamic and metabolic effects of oral hydrocortisone (F) admin-
istration in man. J.A. Whitworib, J.M.C. Connell, A.F. Lever, R.
Fraser, Department of Nephrology, Royal Melbourne Hospital,
Melbourne, Australia, and MRC Blood Pressure Unit, Glasgow, Scot-
land, United Kin gdom. Steroid therapy is used widely in management
of renal disease. However, although the features of iatrogcnic
Cushings's syndrome are well recognized, the hcmodynamic and met-
abolic consequences of steroid administration have not been systemat-
ically examined. Six laboratory workers (age 24 to 48 years) on a diet
with ISO mmnl Na and 70 mmol K were given F 50 mg orally, 6 hourly
for five days. P. cortisol rose from 11 + 1 to 31 2 tg/lOO ml (P <0.01).
Systolic blood pressure rose from 116 + 1 to 121 4mm Hg, P <0.01,
with no change in diastolic pressure. Pulse fell from 65 2 to 58 3
beats/mm, P < 0.05. Body weight increased from 71.0 2.1 to 72.0
2.2 kg (P < 0.001). P. [Nal rose from 139 Ito 141 1 mmol/liter (P
0.01) and p. [K] fell from 4.2 + 0.1 to 3.7 + 0.1 mmol/liter (P <
0.001). [Cl] and IHCO3] were unchanged. P. urea fell from 5.7 0.2 to
5.1 0.5mmol/liter (P 0.05) and p. creatinine from 90 3 to 77 0.5
jzmol/liter (P 0.05). P. alkaline phosphatase felt from 69 + 5 to 57
4 i.u/liter (P 0.001). The liver enzyme AST fell from 16 Ito 12
2 i,u/liter (P < 0.01), but there were no changes in ALT or yUT. P.
albumin fell from 41 1 to 36 1 g/litcr (P 0.00!). Total p. protein
fell from 60 Ito 54 54 I g/liter (P 0.001). Corrected p. calcium
and p. phosphate were unchanged. Uric acid fell from 0.37 + 0.02 to
0.24 + 0.01 mmol/liter (P 0.02). Urine volume was unchanged but
there was a diuresis on F withdrawal, 1.35 0.1 liter to 2.31 0.24
liter, P 0.001. There was initial urine sodium retention followed by a
natriuresis on F withdrawal, 126 8 mmol/day control, 60 9 (P
0.01) on day 1, 306 25 mmol/Iiter post-F, (P 0.001). Crcatinine
clearance was unchanged. Hemoglobin and hcmatocrit (42 1 to 34
1%, P 0.001) fell. There was a rise in white cell count from 4.8 0.3
to 7.1 0.7/mm3 (P 0.001) and a fall in lymphocyte count from 31
2 to 23 + 2% (P 0.01). Platelet count was unchanged. Plasma volume
rose from 3.14 0.08 to 3.9 0.14 liter, (P 0.01). These results
indicate that oral steroid administration invariably produces substantial
hemodynamic and metabolic perturbations.
Improved dietary management of children with chronic renal failure.
K.F. Jureidini, M.J. van Renen, L. Daniels, G.N. Hill, R.J. Hogg, T.R.
South wood, R. Vining, Renal, Dietetics, Pharmacy and Chemical
Pathology Departments, Adelaide Children's Hospital, Adelaide,
South Australia. A strict low phosphate and protein diet with keto acid
precursors of the essential amino acids and histidine was evaluated in 19
children with chronic renal failure. We monitored the effect on growth,
well being, metabolism, bone disease and renal function. The study diet
differed from conventional diet for chronic renal failure as below.
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Conventional diet Study diet
Phosphate restriciton Nil Intense
Protein 2 g/Kg/day 1.2 g/Kg/day
Keto acid mixture Nil 0.3 g/Kglday
Keto acid precursors of the essential amino acids and histidine were
given as a relatively palatable orange flavored drink (Sharp Laborato-
ries) or a sugar—coated granule form (Ketoperlen - Pfrimmer). Both
groups received bicarbonate to normalize serum levels, phosphate
binding gels to normalize serum phosphate, and 1,25 DHCC to normal-
ize serum alkaline phosphatase and keep serum calcium at the upper
range of normal. Fourteen children on the study diet had previously
been on conventional management for at least 12 months and acted as
their own controls. Five had not previously been on any dietary
management. Monitoring included both intact and mid-molecule para-
thyroid hormone (PTH) assays, growth measurements, activity and
psychological acceptance, multiple biochemical analysis of blood and
urine, bone assessment and serial GFR measurements. After 18
months, the diet continued to be generally well tolerated. Compared
with the conventional diet, patients have continued to show signifi-
cantly improved growth velocity, bone disease, general activity, fall in
urea levels, reduced bicarbonate requirements, and normalization of
PTH levels. GFR has not significantly changed after one year. Serum
lipid studies have shown general improvement and marked improve-
ment in those previously untreated. The study diet appears to be well
tolerated with most indices significantly improved and no evidence of
any deleterious effects.
Typing of glomerular mononuclear cells associated with glomerular
rejection. Y. Hiki, A.S.-Y. Leong, T.H. Matthew, A.E. Seymour, V.
Pascoe, A.J. Woodroffe, Renal Units, Royal Adelaide, Queen
Elizabeth Hospitals, and Division of Tissue Pathology, IMVS,
Adelaide, South Australia. To investigate the pathogenesis of glomer-
ular transplant rejection (GTR), we have analyzed intraglomerular
mononuclear cells from 20 biopsies with typical features of GTR
(segmental or global occlusion of capillaires by swollen cells). These
were compared with 10 biopsies showing cellular rejection but no
glomerular pathology (CTR). Microwave fixation and an avidin—biotin
immunoperoxidase technique were used with the following monoclonal
antibodies; Leul & OKT3, Leu3a+b & OKT4, OKT8, OKB7, OKM1
and OKDR. The results (Table) showed a significant increase of T cells
(leul, OKT3), helper T cells (Leu3a+b, OKT4), cytotoxic T cells
(OKT8) and monocytes (OKMI) in the patients with GTR compared
with CTR patients (all P < 0.001, Mann—Whitney U test). Of the T cell
subsets, cytotoxic T cells outnumbered helper T cells by a mean ratio of
3.2:1. These results suggest that T cells, predominantly of the cytotoxic
subset, and monocytes are involved in the mediation of glomerular
rejection.
% Positive glomerular cells
(mean SE)







3.7 0.5a 0.4 0.1
1.3 0.2 0.2 0.1
3.2 0.5a 0.2 0.1
0.2 0.1 0.1 0.1
3.5 0.6a 0.4 0.1
36.1 2.2 30.1 1.1
a < 0.001
The risks of pregnancy in renal transplantation. P.J. O'Connell, J.F.
Mahony, R.J. Caterson, J.H. Stewart, The Departments of Renal
Medicine, Sydney and Royal North Shore Hospitals, Sydney, N.S. W.,
Australia. In a retrospective review of pregnancy in renal allograft
recipients from 1974 to 1985, 11 women had 18 pregnancies. There were
three surgical abortions, nine live births including one set of twins, five
intra-uterine deaths (IUDS) and one miscarriage; one pregnancy is
currently in its third trimester. The initial mean serum creatinine was
0.12 mmol/liter (range 0.08 to 0.20) and only two women had living
donor grafts. Azathioprine and prednisolone were used for immunosup-
pression except in one case treated with Cyclosporin A and
prednisolone. Twelve pregnancies in seven women had worsening of
hypertension or developed hypertension during pregnancy. Proteinuria
was present in 11 pregnancies. Seven pregnancies were associated with
a deterioration in renal function; three were due to hydronephrosis,
three to recurrent glomerulonephritis and one to rejection. Of nine live
births, six were by vaginal delivery and three by cesarean section
(including twins). Six were female and three male. The average gesta-
tion was 34.5 weeks and only one reached 38 weeks. The mean birth
weight was 2027 g with four neonates small for gestational age. One
male infant died at day three from intraventricular hemorrhage and
hyaline membrane disease; there were no abnormalities in the remain-
der. Of the five IUDs, one was noted to have hydrocephalus, and three
were small for gestational age. In conclusion, there is considerable risk
to both mother and fetus in most cases. None of the pregnancies in this
series were uncomplicated and the chance of a live baby was 64%.
Cefotaxime: It's use in CAPD associated peritonitis. Ci. Wood, N.M.
Thomson, R.C. Atkins, Department of Nephrology, Prince Henry's
Hospital, Melbourne, Australia. Continuous ambulatory peritoneal
dialysis, (CAPD) is now accepted as a suitable treatment for patients
with end—stage renal failure. The major complication, however, is the
high incidence of peritonitis and effective, rapid treatment of these
peritonitis episodes is important to minimize patient morbidity and
perhaps, mortality. The initial choice of antibiotic should therefore
effectively cover the major types of causative organisms. Cefotaxime, a
new broad—spectrum cephalosporin with both gram—positive and
entensive gram—negative cover should be very effective in the treatment
of CAPD-associated peritonitis. Between December 1984 and August
1985 all CAPD patients with peritonitis at P.H.H. (Meib.) have received
intraperitoneal Cefotaxime, I g as loading dose then 100 mg/liter as the
primary antibiotic therapy. This antibiotic was continued for 14 days
and changed only if it was apparent that the peritonitis episode was not
improving or side effects occurred. Forty peritonitis episodes occurred
in 29 patients during this time with clinical cure resulting in 27 of these
episodes. Cefotaxime was discontinued on 13 occasions giving an
overall failure rate of 33%. Although high, this is similar to our previous
experience using other initial antibiotic regimes which has seen a 30 to
40% failure rate. The reasons for discontinuation include: resistant
organisms (four multiple antibiotic resistant staphylococci, two gram
negative bacilli, one Diphtheroid. one Acinetobacter), no clinical re-
sponse despite invitro sensitivity of organisms (four episodes) and drug
side effects (one episode). No relapse of peritonitis occurred following
completion of intraperitoneal Cefotaxime. We conclude that the broad
antibacterial spectrum of Cefotaxime conveys suitability as treatment
of CAPD-associated peritonitis except in patients with cephalosporin
resistant organisms and is a suitable first—line drug where the organism
is not known.
The Redy sorbent system permits nutrient administration during
hemodialysis. E. Feinstein, P. Friedman, M. Roberts, S.S. Massry,
Division qf IVephrology, University of Southern California School of
Medicine and Organon Teknika Corporation, Los Angeles, California,
U.S.A. Patients with acute and chronic renal failure frequently need
parenteral nutrition. Addition of glucose and amino acids to
hemodialysate allows efficient uptake of these nutrients by the patient.
Using single pass hemodialysis required marked reduction (below 50
mI/mm) in dialysate flow rate, resulting in low urea and creatinine
clearances. The purpose of this study was to evaluate the Redy sorbent
system as a means of nutrient administration. Standard hemodialysis
was performed with bicarbonate dialysate. Duration of dialysis therapy
was four hours with a 0.77 square meter hollow fiber dialyzer using
blood and dialysate flow rates of 200 mI/mm. Glucose was added to the
dialysate at hourly intervals in amounts of 48 to 120 g (total of 192 to 384
g). All patients received regular insulin (one to three units/hour) by
intravenous infusion. Varying amounts of glucose and insulin were used
in order to give the maximum amount of glucose while minimizing
intradialytic hyperglycemia and post-dialysis hypoglycemia. Forty g of






—0/0 G0' 1' 2' 3'
48 48 48 48 42 81
96 96 0 0 52 99
120 96 0 0 53 114
#20 120 0 0 45 107
120 96 96 72 60 229
The glucosc clearance was SI 10 mI/mm (so). All patients became
hyperglycemic during therapy and hypoglycemic post-dialysis. These
resolts demonstrate that addition of glucose to the dialysate in the
sorbent hemodialysis system permits efficient administration of glu-
cose. This represents 304 to 859 kilocalories per dialysis treatment. The
post-dialysis hypoglycemic is probably due to inadcquate control of
mtradialytic hyperglycemia.
The pharinacokineties and pharmacodynamics of nifedipine in normal
volunteers and in patients with stahle renal failure. BA. Rohson, RB.
Boiley, JR. Shormon, E.J. Begg, Deportment of Nephro/ogy,
Christchoreh Hospitol, New Zeolood. 'ihe pharmacokinctics and
pharmacodynamics of two formulations of nifedipine, 10 mg capsule
and 20mg slow release tablet, were studied in five healthy volunteers (3
males, 2 females), creatinine clearance (mean so 2.2 0.2 ml/s) and
tO patients with stable chronic renal failure, (5 males, 5 females),
creatininc clearance (mean so 0.27 0.19 ml/s), not on dialysis.
Plasma nifedipine concentrations were determined by a specific
gas—liquid chromatographic method. The limit of sensitivity for the
assay was I jig/liter. The results arc detailed in the Table. There were
no statistically significant differences between the volunteers nd the
renal failure patients for any of the calculated parameters for both
formulations of oifedipioe. The 20 mg tablet gave a profile in both
groups of subjects of a sustained release preparation with a lower
maximum concentration (Cmax) and a longer time for maximum
concentrations ('l'max) to occur. Large inter-individual variations in the
calculated data is consistent with the known variability in bioavail-
ability due to first pass metabolism. The observed reduction in blood
pressure was consistent with the pharmacokinetic data, with the
maximum effect occuring at the Tmax for both formulations. The
reduction in blood pressure was not statistically significant, but there
was a compensatory increase in heart rate. In contrast the reduction in
blood pressure in the renal failure patients was statistically significant
and there was no compensatory increase in heart rate.
10 mg
capsule 20 mg tablet
Volunteers
AUC (h jig/liter) 115 10 197 67
Tmax (h) 0.5 0.4 2.0 0.5
Cmax (pg/liter) 54.9 16.3 26.3 5.9
Renal failure patients
AUC (h jig/liter) 160 42 220 54
Tmax (h) 1.5 0.7 3.5 0,58
Cmax (jig/titer) 30.5 it 11.4 23.8 4.1
Inhibition of enzymatic disposal of cateeholamines in renal failure. R.
Vondongc, Jiso Dovidson, L.J. Be//in, Anne Tunnev, Deportment of
Medicine, Uoiversity of Western Austrolio nod Rovo/ Pert/i Hospitol,
Perth, Anstro/jo. Plasma li-cc and sulphate conjugated cateeholamines
(CA) are elevated in chronic renal failure (CRF), presumably due to
impaired renal clearance. However, reduced metabolic inactivation via
enzymatic pathways nsay also contribute. This study examines the
hypothesis that enzymatic methylatiun is inhibited in CRF, resulting in
increased concentration of free CA and the utilization of alternative
inactivating pathways, including sulphation. Plasma free and sulphated
noradrcnalinc (NA) and adrenaline (A) were measured by radioenzy-
matie assay using internal standards in six patients with CRF before and
after hemodialysis. Free and conjugated NA (0.75 1 0.42 and 7.2 1.5
ng/ml, respectively) and A (0.06 0.02 and 4.41 1.42) were higher
before dialysis than after (0.39 0.12 and 3.6 1 1.0 for NA; 0.037 1
0-008 aod 1.6 1 0.6 for A). These levels arc higher than normal free and
conjugated NA (0.27 0.01 and 0.95 0.06, respectively) and A (0.05
0.005 and 0.19 0.OlS)(N=46). The percentage of total CA which is
free was smaller in CRE (9.3 2.4% for NA and 2.1 1 0.3% for A) than
in normal (23 1% and 23 2%) plasma. Compared with pooled
normal plasma, 1H-methylation of internal standard (100 pg) was
consistently inhibited in CRE plasma by 21 1 2.6% for NA and 15.4
2.2% fur A. Dialysis incompletely removed this inhibitory effect. These
lindings confirm an inhibitory efi'ect of uremic plasma on enzymatic
methylation, and therefore the inactivation of CA. 'The increase in
sulphatcd CA, although largely due to impaired clearance, may also
reflect enhanced conjugation in order to maintain adequate
extra—neuronal disposal.
Surgical management of renovascular hypertension—a comparison
between fibromuscular hyperplasia and atherosclerotic lesions: A 20 year
study. J. Hori'oth, W. FLvcher, J. Moy, B. Wongh, A.G.R .Shei/, A.
Eyres, D. Ti//er, J. Johnson, G.G. Duggin, B. Ho/I, Deportment of
Reno/ Medicine, Rovo/ Prince Alfred Hospito/, Cotnperdown NSW,
Austrolio. In a 20 year period. 142 patients had surgery for the
management of renuvascular hypertension. Forty—four patients had
librumuscular hyperplasia (FMH) and 98 patients had atherosclerosis
(AS). At follow—up (FU) patient survival, blood pressure (BP), number
of antihypcrtcnsivc drugs (DR), and serum creatinine (S.Cr) was
documented. The results arc expressed as mean so and significance
isP <0.05. At operation the patients with FMH were 34 it 11 years old.
Patient survival at 15 years was 91%. At EU Ito 228 months (100 6),
there was a significant fall in BP (185/113 1 35/21 vs. 134/84 17/10mm
Hg), and a reduction in DR (2.6 1.5 vs(. 1.4 1.2). Twenty—seven of
the 44 patients were available for repeat RA. Five patients had graft
occlusion, four had ncphrcctomy, and the other repaired. Two further
patients had narrowing of the graft with no adverse effect on BP. Nine
of the remaining 20 patients had progression of FMH and the level of BP
in those 11 patients compared to patients with no change was not
different. At operation the 98 patients with AS were 52 11 years of
age. Patient survival at tO years was 51%. In 34 patients with a
pre-operative S.Cr >200 jimol/liter there was only 16% survival in the
comparable period. The prc-opcrativc BP for the AS group was 195/117
1 37/23 mm Hg and there was a significant reduction in BP (156/92
30/18mm Hg) and DR(3 1.4 vs 2.2 1.2) at the time of EU Ito 240
months (mean 58 1 40) following surgery, but there was no change in
renal function for the group as a whole. Forty—six patients had repeat
RA. There were II graft occlusions, three graft stenoses and progres-
sion of AS in 13 patients. The remaining 19 patients had no further
abnormality on RA. There was no correlation between level of blood
pressure. or renal function and RA finding at FU. Surgical management
results in different outcomes for the two groups of patients. to trying to
establish the natural history and the impact of treatment strategy these
diseases should be considered separately.
Chronic progressive renal lesions induced hy lithium. RU. Wo/ker, P.
Kiocnid—Smith, Deportment of Nephro/ogy. The Roynl Melbourne
Hospitol, Por/<vi/le 3050, V/c/orb, Anstrolio. New Zealand white
rabbits, eight fed lithium (50 to 250 mmol/litcr of 1.iCl/kg food (Li)] and
seven controls (C) had sequential open renal biopsies at 0, I, 3, 6 and #2
months. Quantitated histological changes; interstitial fibrosis (IF),
tubular atrophy (TA), cast foruiatiou (CA) (determined by point count-
ing or digitization) and glomerular sclerosis (US) (% selerosed
glomeruli) were more marked in Li compared with C from as early as
one mooth (tE; P < 0.02, TA; P C 0.05, CA; P C 0.05); and up to 12
months (US; I' C 0.05). Distal tubular dilatation and microcyst forma-
tion (determined by digitization) was also marked in Li compared with
C from as early as one month (P C 0.051. The degree of distal tubular
dilatation and other changes of chronic focal interstitial ncphropathy
tended to progress with duration of lithium exposure. At 12 months
particularly, numerous mitotic figures were observed in tubular cells
lining segments of the distal ocphron in Li and macroscopically. Li
kidneys were pale and granular and exhibited microcysts. Impairment
of glomerular filtration (raised blood urea; P C 0.02, and raised serum
creatininc; P C 0-05); were late features (12 months) in Li animals.
The results of five studies are as follows:
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Polyuria, although evident in Li at one month did not appear to progress
with duration of lithium exposure. This study confirms that lithium
induces chronic lesions in the rabbit kidney, identifies similarities with
the lithium—induced histological features described in human kidneys,
and also suggests a possible animal model for other "cystic" kidney
diseases.
Urinary tract disease in aboriginal subjects in south Australia. D.J.
Pugsley, B. Grime, E. Butler, A.J. Esterman, Renal Unit, Queen
Elizabeth Hospital, Adelaide, Aboriginal Health Organization of South
Australia and Division of Epidemiology of the South Australian Health
Commission, Australia. Aboriginal subjects (3103) were surveyed for
the presence of urinary tract disease (UTD), using a cluster analysis
technique, in urban, rural, and traditional tribal areas of South Australia
between 1982 and 1984. As defined by the presence of proteinuria
and/or hematuria (1+ on dipstick—Ames Co.) 16% of all subjects had
UTD. The prevalence of UTD rose with increasing body mass index
and also, until the fifth decade, with increasing age. Six percent of all
subjects had 2+ proteinuria on testing. Fifteen percent of all subjects
with UTD were diabetic (overall prevalence of diabetes in this popula-
tion = 6%) and 40% of all diabetics had evidence of UTD. Fourteen
subjects (0.45%) had elevated blood levels of creatinine and urea giving
a prevalance rate for renal failure of 1:215 (4,700 per million). Compar-
ison with an estimated prevalence rate of renal failure in the South
Australian population, suggests that renal failure is likely to occur ten
times more frequently in the Aboriginal population.
Renal disease and familial IgA nephropathy in an aboriginal family.
P.J. O'Connell, L.S. Ibels, M. Harris, MA. Thomas, Department o.f
Renal Medicine, Royal North Shore Hospital, Sydney, N.S.W., Aus-
tralia. An Aboriginal family which was noted to have a high incidence
of renal disease was investigated. Twenty—five of 76 members from four
generations had hematuria on screening. From this group, 48 members
(21 males, 27 females, age range two to 86 years) from the main family
with renal disease were studied further. All had repeated urinalyses and
blood pressures measured. Thirteen had serum creatinine and IgA
estimations, 11 had intravenous pyelograms (IVP) and eight renal
biopsies. Twenty—one had hematuria and four hematuria and protein-
uria. Five had hypertension, one a raised serum creatinine, two
elevated serum IgA levels and one cortical scarring on IVP. All those
biopsied (6 males, 2 females) had hematuria, five proteinuria, four
hypertension, and one a raised serum creatinine. Histological, electron
microscopy and immunofluorescent (IF) features were consistent with
IgA nephropathy in five, mild arterial changes consistent with hyper-
tension and diabetes in one, arteriolar C3 disease in one and no IF was
available in one. HLA typing was performed in 27 family members and
there was no difference in antigen frequency in those with igA nephrop-
athy when compared to the rest of the family or those with no renal
disease. HLABI2 and B35 were not present, and HLADR4 was present
in one person with hematuria. This study suggests that the incidence of
renal disease may be high in the Aboriginal community and that IgA
nephropathy may be common in this group.
Acute and chronic potassium tolerance during long—term captopril
therapy in rats. M.J. Field, JR. Lawrence, Department of Medicine,
University of Sydney, Concord Hospital, N.S.W. 2139, Australia. To
determine the effects of chronic inhibition of angiotensin II (All)
synthesis on potassium homeostasis, we studied rats treated continu-
ously for three weeks with captopril (100 mg/kg/day in drinking water).
Animals were divided into three groups, each with a corresponding
untreated control group. Rats in Group I were fed a normal diet, while
Group II rats ate a KCI-supplemented diet (approximately 20 mmol
K/day) for the duration of the study. Group HI animals ate the normal
diet, but were given an acute KCI load at the end of the three—week
observation period, immediately prior to sacrifice. At this time, blood
was taken from animals in all groups for determination of plasma
concentrations of K and aldosterone (Aldo), and adrenal glands were
obtained for light—microscopic measurement of zona glomerulosa (ZG)
width. Results were: (means 5EM, N = 5—7/group; con=Controls, cap
Captopril—treated).

























a p < 0.02, compared to III (con).
b P < 0.001, compared to I (con).
It is concluded: (1) hyperkalaemia is no more likely after an acute or
chronic potassium load in captopril—treated animals than in controls,
given normal renal function; (2) chronic captopril therapy does not
reduce the circulating aldosterone level in animals on control or high-K
diets, but does blunt the rise in Aldo induced by an acute K challenge;
(3) chronic dietary K loading stimulates growth of the adrenal zona
glomerulosa, while long—term suppression of All synthesis with
captopril does not alter ZG morphology.
Natriuretic actions of gut peptides. K.A. Duggan, G.J. Macdonald,
The Prince Henry Hospital, Sydney, Australia. Intravenous infusions of
vasoactive intestinal peptide (VIP) and cholecystokinin octapeptide
(CCK-8) are natriuretic in the rabbit. As significant metabolism of these
peptides occurs in the liver, their renal effects may be mediated by other
compounds. To establish whether VIP and CCK-8 act directly on the
kidney and to define the renal responses to them or their metabolites,
we compared the natriuretic responses to VIP and CCK-8 (l0-— 100
pmol/kg/min) infused intravenously and directly into the renal artery of
six conscious male rabbits. The order of peptide infused and its route of
administration were randomized. Each dose of peptide was infused for
30 minutes, during which blood pressure was recorded and urine
collected. Blood was sampled at the end of each perfusion to determine
renal plasma flow (e.r.p.f.—l'25 Hippuran clearance) and glomerular
filtration rate (g.f.r.—endogenous creatinine clearance). Responses
were assessed by linear regression testing against the logarithm of the
dose of infused peptide. In these doses, VIP had significant effects on
renal circulation without altering arterial pressure or pulse rate. A log
dose—related fall in e.p.r.f. (—r = 0.50P < 0.01) and increase in derived
renal vascular resistance (r = 0.29 P < 0.05) occurred. Total sodium
excretion did not rise significantly, but when corrected for the nonsig-
nificaht fall in g.f.r., a significant increase in fractional sodium excre-
tion, from a control mean of 1.36 to 4.43 (r = 0.45 P < 0.01) occurred.
CCK-8 infusions had no effect on arterial pressure or pulse rate, while
causing a log dose—related fall in e.r.p.f. (—r = 0.35 P < 0.05) and a
significant rise in g.f.r. (r = 0.47 P < 0.05). Total sodium excretion rose
significantly from a control mean of 11.15 mol/min to 40.60 mol/min (r
= 0.46 P < 0.05). However after correcting for the increase in g.f.r.
fractional sodium excretion did not increase significantly. It is con-
cluded that both VIP and CCK-8 directly affect renal sodium excretion,
VIP by acting upon renal tubules and CCK-8 by elevating g.f.r.
Protection of intracellular homeostasis: Evidence for compartmental-
ization of intracellular potassium. W.R. Adam, A.P. Koretsky, M. W.
Weiner, Renal Unit & University of Melbourne Department of Medi-
cine, Heidelberg, Australia; Departments of Medicine and Radiology,
University of California, San Francisco; and Department of Medicine,
Veterans Administration Medical Center, San Francisco, Cal,jirnia,
U.S.A. Following an acute K load, transfer of the potassium to the
intracellular space helps protect the extracellular [KI and the resting
transmembrane potential, at a possible cost of disturbing the intracel-
lular environment. The use of both 39K Nuclear Magnetic Resonance
(NMR) and K selective electrodes to measure K activity and chronic
K' loading (HK), as a physiological model which appears to increase
sequestered K, has provided evidence for intracellular K compart-
mentalization. In liver homogenates from control (C) and HK rats: (a)
addition of RbCl (200 rmole/g) increases the NMR KF signal (zmole/g)
more in HK rats (19.3 3) than control (II 2, P <0.01) consistent
with displacement of K, by Rb, from NMR invisible sites; (b) K
selective electrodes detect less K, as a proportion of total K, in HK
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compared to C rats (17% or approxiniatcly 12 j.tmolc/g, P < 0.0!),
consistent with the presence of a K compartment not seen by the
electrode. Acute K< loading (I mmole) in vivo increases tissue K in
HK liver (7 2 j.tmole/g) and muscle (9 2 jzmole/g) but there was no
change in NMR K. By contrast, in control rats increases iii muscle K+
(12 2 smolc/g), with K F loading, arc associated with increases in
NMR K< (15 3 jzmole/g). These results suggest that some 10 to 15%
of intracellular K is within a compartment and that chronic K loading
leads to an increased capacity of this site. Sequestration of K< into this
compartment may provide protection from changes in intracellular[K].
A cortical gradient in glomerular angiotensin II receptors and their
regulation during altered dietary NaCI intake. F.A.O. Mendelsoh,i, A.
Allen, R. Figdor, University of Melbourne, Deportoieot of Medicine,
Austin Hospital, Heid/ebery'. Victoria. 3084, Australia. Nephronsaris-
ing from superficial glomeruli differ in function and morphology from
deeper, juxtamedullary nephrons. Also juxtaglomerular renin content
and glomerular vasoreactivity to angiotensin It (All) show a cortical
gradient, being highest in superficial glomeruli. Using the technique of
quantitative in vitro autoradiography, we have investigated the regional
distribution of glomerular angiotensin II receptors (AIIR) and assessed
the responses of glomerular and medullary receptors to altered dietary
NaCI intake. Frozen sections (20 Arm) of kidney from Sprague—Dawley
rats were thaw—mounted onto coated slides, incubated with 251-[Sarfl-
All to label AIIR, exposed to x-ray film and quantitated by computer-
ized scanning dcnsitometry. A very high density of AIIR binding was
seen over glomeruli and vasa recta bundles and a moderate density
occurred over the interbundle zone of the outer stripe. A highly
significant gradient in glonserular AIIR was seen: on high salt intake,
AIIR density was 207 7 dpm/nini in superficial glomeruli and 183
S in deep glomeruli (P .c 0.005); this pattern was preserved during five
days of low salt intake being, 185 S dpni/nim2 in superficial glomeruli
and 165 5 in deep glomeruli (P c 0.02). Both superficial and deep
glomeruli showed significant down—regulation of AIIR during low salt
intake (P < 0.02 and P < 0.05, respectively) at a time when circulating
and intrarenal All level were elevated. These data reveal a significant
gradient of glomerular AIIR. Receptors in both superlicial and deep
glomeruli down—regulate during low NaC1 intake as do the more
abundant Alt receptors associated with vasa recta bundles.
Ischernic acute renal failure (ARF) ts worsened hy phosphate depletion
(PD) but not hy hypercalcemia (HC). D.C.H. Harris, Ti. Burke, B. W.
Schner, Deportment of Medicine, University of Colorado School of
Medicine, Denver, Colorado, LISA. PD worsens the severity of both the
functional injury and the impairment in mitochondrial (Mito) respiration
which attend isehemic ARF. Because PD, induced with the phosphate
(P) binder dihydroxyaluminum aminoacetate (DHAAA. IS g%), is also
associated with HC'. the present study exaouned the effect on ischemic
ARF of MC alone achieved by adding dihydrotachysterol (D. 4.25
mg/kg diet) to the food of rats who were pair fed with controls (C). After
10 days both renal arteries and veins were clamped for 50 minutes; rats
were sacrificed 24 hours later. Serum P1 (mmol/litcr) was lower in
Dl-IAAA (1.25) than D (2.25, P <0.001) and C (2.12,1' <0.001), and P1
excretion (mmol/24 hr) was higher in D (6.80) than DIIAAA (0.13, P
0.OOt) and C (2.55, P < 0.001). Prior to isehemia, D rats had greater DC
(3.39 mmol/liter) than DIIAAA (2.75 niniol/liter, P < 0.001) and C (2.53
mmol/liter P <:0.00!). and greater tissue and Mito Ca, yet Ca excretion
(mmol/24 hr) was higher in DHAAA (6.90) than D (3.73, P < 0.005) and
C (0.t9, P 'c 0.001). Twenty—four hours after clamping, serum ereati-
nine (mmol/liter) was lower in D (0.249. P < 0.005) and C (0.270. P
0.05) than DHAAA (0.357) and CCr (p.1/mm) was higher in both D (109,
P < 0.05) and C (Ill, P C 0.05) than DHAAA (7.76). State 3 (S), State
4 (S4 and uncoupled (FCCP) respiration fell to a greater extent in
DHAAA (54 47%, S4 39%, FCCP 49%) than D (S4 27%, P C 0.05; S4
17%. P C. 0.02; FCCP 27%. P < 0.02) and C (S4 9%, S4 11%, FCCP
16%, P C 0.005) rats..1he increase in tissue and Mito Ca after ischemia
was similar in I) and DHAAA rats. These results suggest that the
detrimental effect of PD on ischemic ARE is independent of concomi-
tant HC, and that the tissue and Mito Ca accumulation may be an
cpiphenomenon in this model.
Phosphate restriction prevents the concentrating defect of
hypercalcemia (HC). D.C.!!. Harris, PA. Gohou, 11W. Srhrier, l)e-
portrnerit of Medicine, flnieer,sitv of Colorado School of Medicine,
Denver, Colorodo, USA. 'l'hc concentrating defect of DC is well
recognized, but the mechanism is unknown. To examine the mechanism
of this concentrating defect in HC. the effect of I-IC alone was compared
to that of HC which accompanies phosphate restriction. Three groups
of rats (N = 18 each) were pair fed a normal phosphorus diet with
(DHT) or without (control) the addition of dihydrotachysterol (5.25
mg/kg diet( or an otherwise identical low phosphorus diet without DHT
(PD). At'ter 10 days of diet, serum inorganic phosphorus was lower in
PD (1.23 mmol/liter, 1' C 0.001) than in DHT (2.30 mmol/liter) or control
(2.115 mmol/liter) rats. Weight loss was similar in the three groups, as
was osmolar excretion in control (34.12 mOsm/24 hr), PD (35.71
mOsm/24 hr) and DHT (32.37 mOsm/24 fir) rats.. In addition, serum
Ca2F was higher than control (2.6! mmol/liter) in both PD (2.96
mmol/liter) and DHT (3.02 mmol/liter) rats, both Pc: 0.001. Despite the
similar degree of HC in PD and DHI rats, maximal Uosm after 24 flours
of dehydration was lower only in DHT (244! niOsm/kg, P C 0.001),
compared to PD (3332 mOsm/kg) and control (3263 mOsm/kg) rats.
Polydipsia and diuresis were greater in DHT (41.8 and 28.1 mI/day,
respectively, P C 0.05) than in PD (34.2 and 20.1 mI/day) and control
(32.4 and 18.1 mI/day) rats. Moreover, urinary Ca2 excretion was
higher in PD (8.88 mmol/day, P C 0.05) than in DHT (4.93 mmol/day) or
control (3.37 nsmol/day) rats, and tissue Ca content was greater in DHT
(7.96 inniol/rng dry wt, P < 0.005) than in control (5.28 nmol/mng dry wt)
and PD (5.87 nmol/mg dry wt) rats. In conclusion, phosphate restriction
prevents the concentrating defect of HC. This protective effect may he
mediated by the hypercalciuria of phosphate restriction and accompa-
nying decrease in tissue Ca accumulation.
Hydrocarbon exposure, renal disease and membranous glomer-
ulopathy. R.S. Nonro, Deportnient of Nephrology, Rriyol Newcastle
hospital, Newcastle, NSW, Australia. Hydrocarbon [DC] exposure
was assessed in 90 patients with renal disease (membranous
glomerulopathy [MGI N = 24, glomerulonephritis [GN[ N = 40,
analgesic nephropathy [AN] N IS, polycystic kidney disease [PCK]
N = II) and 16 controls by measurement of blood HC levels. Only
45.4% of PCK patients had DDT. and 36.4%. had hexachlorohenzene
[HCB] exposure compared to 66.7 to 95.8% of MG, GN and AN
patients, and 75 and 87.5% of controls (P < 0.005). Dieldrin [DLD] was
found only in patients with MG (33.5%) (P C (1.0005) and (iN (5%).
Except for I MG patient with a blood DLD level offlI pph, all remaining
patients and controls had HC blood levels below the maximum recom-
mended level (50 ppb). More patients with MG and 1)11) had micro-
scopic hematuria (6 of 8 patients, P <0.05) and an industrial occupation
(5 of 8 patients, P 0.025) than MG patients without DLD. Only I of
8 MC patients with DLD had a reduced GFR compared to 10 of 16
patients without DUD (P -C 0.1 >0.05). Conclusions'. (1) there is a
significant association between DLD exposure and MG, (2) microscopic
hematuria is common in MG with DLD exposure, and (3) HCs are more
commonly found in patients with acquired renal disease than in PCK
disease.
Urinary nitrite in symptomatic and asymptomatic urinary infections.
HR. Powell, Royal Children's Hospital, Melbourne, Austrolio. The
dipstick test for urinary nitrite is negative in 40 to 50% of symptoniatie
urinary infections. However, the impression was gained that the test
may he more reliable in asymptomatic patients attending a follow—up
clinic. The nitrite test was positive in 83 of 100 outpatients with
asymptomatic urinary infection attending a follow—up clinic because of
known predisposition to urinary infection. These patients had  l0
bacteria/mI in midstream urine specimens. In contrast, only 104 (52%)
of 200 symnptomatic patients with urinary infection attending an
Emergency Department had a positive nitrite test. The difference was
highly significant (P C 0.0001). By addition of u broth culture of F. coli
to sterile urine it was found that four to six flours incubation at 37°C was
m'equimed before the nitrite test became positive. 'this suggests that
frequency of micturition in urinary infection reduces the reliability of
the nitrite test. However, the higher sensitivity of the test in asympto-
nsatic patients, together with its high specificity, suggests its suitability
for regular home testing of patients with known predisposition to
urinary infection with the aim of detecting and treating infections before
symptoms arise. Weekly home tests appear niost smutable.
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Diabetic end—stage renal failure (ESRF): 11 years experience. T.J.
Thompson, Renal Unit, Wellington Hospital, Wellington, New Zea-
land. Over the last 11 years, diabetic patients have formed an increasing
proportion of new patients entering the Wellington Hospital dialysis and
transplantation program. Over the last three years they averaged 27% of
new patients. Between 1.1.75 and 31.12.85, 47 of 67 patients referred
were accepted for treatment. There were 30 Europeans (64%) with a
mean age of 45 years. Seventy—seven percent had type I diabetes. There
were 16 Maoris (34%) with a mean age of 51 years. Eighty—one percent
had type II diabetes. At the time of presentation all patients had
retinopathy, ten patients were blind and a further 27 had received
photocoagulation. There was clinical evidence of ischemic heart disease
in 14 patients and 27 had peripheral vascular disease. Forty patients
were hypertensive and 32 had neuropathy. The initial treatment was
CAPD in 38 patients (81%), home hemodialysis (HH) in five patients,
hospital hemodialysis in three patients and live related transplant in one
patient. At completion of training 32% of patients resumed full—time
work and 38% part—time. There have been 22 deaths. Patient survival
for CAPD was 45% at four years (51% for non-diabetics [ND]. The four
year patient survival for HH was 20% (80% for ND). For transplanta-
tion (12 patients) patient survival was 24% at four years (81% for ND).
Graft survival was 36% at three years (59% for ND) but zero at four
years. Despite a poorer overall survival compared to non-diabetics,
treatment of diabetic patients has in many cases proved rewarding. The
high proportion of Maoris (10% of the population) reflects a higher
prevalence of type II diabetes.
Lupus nephritis: Clinical and pathological correlation. B. Leaker, K.F.
Fairley, J. Dowling, P. Kincaid—Smith, Department of Nephrology,
The Royal Melbourne Hospital, Parkville, 3050, Victoria, Australia.
The clinical course of 135 patients with lupus nephritis was examined
long—term as part of a prospective study. Biopsies were classified
according to modified WHO criteria and showed 17% of patients had
mild mesangial lesions, 10% focal lesions, 21% mild diffuse proliferative
lesions, 37% severe diffuse proliferative lesions and 15% membranous
lesions. Overall patient survival of 83% and 65% at five and 10 years,
respectively, from onset of nephritis was similar to other recently
published series. In contrast to the latter, the severe proliferative group
had a significantly worse outcome than the other histological groups (P
< 0.01) and only patients in this group progressed to end—stage renal
failure. Hematuria was more common (P < 0.05) in the severe group
and there was a striking correlation between histologic activity and
urinary renal cell count (r 0.74, P < 0.001). There was no correlation
between serum creatinine, proteinuria or chronic lesions with urinary
red cell count. In contrast to a previous study, there was no correlation
between the presence of hyaline thrombi on initial biopsy and subse-
quent development of glomerular sclerosis. Although the value of renal
biopsy has been questioned, we suggest that it remains a most impor-
tant investigation in the management of lupus nephritis. Determination
of urinary red cell count provides a most useful monitor of disease
activity and response to treatment.
The effect of eicosapentanoic acid on active lupus nephritis. B. Leaker,
R. Quist, N. Salehi, P. Kincaid—Smith, Department of Nephrology,
Nuclear Medicine, The Royal Melbourne Hospital, Parkville, 3050,
Victoria, Australia. Eicosapentanoic acid (EPA), a naturally occurring
fatty acid, has been used in the treatment of atherosclerosis and renal
disease. We have examined the effect of dietary EPA on the course of
lupus nephritis in a historically controlled trial. Ten female patients,
median age 29, with a diagnosis of SLE showed either diffuse prolifer-
ative or focal lesions on renal biopsy. All had persistent active urinary
sediment despite conventional steroid and immunosuppressive therapy.
In our experience, quantitative urinary red cell counts (Urbc) provide
the most reliable non-invasive indicator of renal histological activity.
All patients showed mean Urbc counts >50,000 rbc/ml measured on at
least three occasions at monthly intervals prior to the start of the trial.
Patients were treated with 3.2 g of EPA in addition to previous therapy.
Seven of 10 patients showed a significant reduction in mean Urbc from
median 143,000 (50 to 600,000) to 20,000 (8,000 to 400,000), P < 0.01.
Three patients did not respond, one of whom was non-compliant. There
was no change in proteinuria, GFR measured by CEDTA clearance fell
significantly with treatment from median 89(44 to 121) to 77(39 to 98)
ml/min/l.73 m2, P < 0.01. After stopping EPA therapy GFR rose to
median 84(37 to 109), although the difference failed to achieve signifi-
cance. Triglyceride levels fell significantly on treatment median
1.42(0.76 to 2.56) to median 1.19(0.5 to 1.8lmmol/liter, P < 0.01. Four
patients had decreased platelet survival median 5.35(3.4 to 5.6) mea-
sured by mW oxine labelling method which returned to normal (8 to 10
days) on treatment. EPA may be a useful adjunctive therapy in the
treatment of lupus nephritis, but may require regular monitoring of
GFR.
Nephrocalcinosis and urinary tract anomalies in premature infants.
N.F. Woolfield, R.R. Haslam, G. LeQuesne, K.F. Jureidini, Renal and
Ultrasound Units, Adelaide Children's Hospital, and Neonatal Inten-
sive Care Unit, Queen Victoria Hospital, Adelaide, South Australia.
The incidence of nephrocalcinosis and urinary tract anomalies in
premature infants (birth weight < 1500 g) was assessed. In their twelfth
month of life, an ultrasound examination of the urinary tract was
performed. Urine was collected at the same time and analysed for
electrolytes, creatinine, osmolality, pH and B2 microglobulin. Urine
microscopy was also performed. Retrospective analysis of case records
was made to assess factors of importance in the etiology of nephrocal-
cinosis. A total of 36 infants had ultrasounds performed. Three infants
were found to have nephrocalcinosis. All had been on long—term
frusemide for bronchopulmonary dysplasia. None had renal calculi
present. Urinary microscopy, electrolyte and B2 microglobulin showed
no consistent differences compared to other infants in the study without
nephrocalcinosis. Five other children had urinary tract anomalies.
While two of these had uncomplicated duplications of collecting sys-
tems, the other three had major anomalies. One had a duplication of the
collecting system with a ureterocoele. Another had bilateral pelvi-
ureteric junction obstruction, and a third had a shrunken kidney on the
left with a dilated ureter on that side. A micturating cystourethrogram
confirmed vesico-ureteric reflux. Conclusions: three infants of this
population of premature infants had nephrocalcinosis, presumably due
to long—term frusemide therapy. It had no effect on renal function as
measured by urine electrolytes or B2 microglobulin. Five others had
urinary tract anomalies. While two were uncomplicated, the other three
represent major anomalies, an incidence of eight per cent. A case can be
made for the ultrasound examination of urinary tracts of all premature
low birth weight infants.
Raised IgA anti-pneumococcal antibodies in IgA nephropathy (IgA
GN). PA. Drew, W.N. Nieuwhof, A.R. Clarkson, andA.J. Woodroffe,
Department of Surgery and Renal Unit, Royal Adelaide Hospital,
South Australia and The State Health Laboraiory, Queen Elizabeth II
Medical Centre, Western Australia. A postulated cause of IgA GN is
the overproduction of IgA polymers and complexes in response to
antigens presented to mucosal surfaces. To test this, we have measured
the concentration of specific antibody to pneumococcal polysac-
charides derived from common respiratory commensals and/or patho-
gens. Sera from 35 patients with IgA GN, six with SLE, eight with
MGN and six with anti-GBM GN, and from 20 controls (C) were
assayed. The concentrations of IgG and IgA specific for each of five
pneumococcal polysaccharides (serotypes 2, 7F, 9N, 14 and 23F) were
determined by ELISA. The results from the SLE, MGN and anti-GBM
GN patients, being similar, were pooled and used as a patient control
group (PC). Groups were compared using the Wilcoxon test or the Chi
square test and differences were considered significant when P < 0.05.
There was no difference in the concentration of IgG antibody for any of
the serotypes between IgA GN and C, but the PC group had signifi-
cantly lower concentrations than either IgA GN or C. In contrast, there
was no significant difference between the PC group and C in the
concentration of IgA antibody to four of the serotypes, but the
concentration of IgA was significantly increased in IgA GN compared
to both groups. (There was insufficient IgA antibody to serotype 2 to
detect in the assay system used.) We conclude that IgA GN patients
have significantly elevated concentrations of IgA, but not IgG, to
common respiratory tract bacteria compared to normal controls or
patients with other forms of nephritis.
Lead intoxication on the Sydney Harbour Bridge. L.S. Ibels, C.A.
Pollock, Department of Renal Medicine, Royal North Shore Hospital,
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St. Leonards, N.S.W., Australia. Lead intoxication is far more preva-
lent than recognized in those exposed to lead fumes and dust in
industry. The early symptoms of lead intoxication are subtle and
non-specific. Blood lead levels are a poor reflection of total body lead
stores and potential toxicity but are frequently used as the only
screening test of lead intoxication. Calcium EDTA chelation testing is a
more sensitive test to detect total body lead stores. We report six cases
of men employed on the Sydney Harbour Bridge with significant lead
intoxication, all of whom have symptomatically benefitted from calcium
EDTA chelation therapy. The bridge workers were involved with
removal of lead based paint from Harbour Bridge for between six to
twenty—eight years. Symptoms compatible with lead intoxication had
been present for several years at the time of their first screening with a
blood lead level in 1985. An EDTA chelation test showed a high lead
load in all patients. Two had significant renal disease with chronic
interstitial fibrosis on renal biopsy. EDTA chelation therapy in all six
patients resulted in considerable symptomatic improvement. It is ap-
parent that screening in the industrially exposed must be undertaken on
a regular basis and the diagnosis of lead poisoning must be considered
if considerable morbidity is to be avoided.
Acute renal failure due to focal necrotizing glomerulonephritis in a
patient with non-Hodgkin's lymphoma: Resolution with treatment of
lymphoma. L.S. Ihels, C.A. Pollock, J.A. Levi, R.P. Eckstein, P.
Wake ford, Department of Renal Medicine Royal North Shore Hospi-
tal, St. Leonards, N.S. W., Australia. Renal involvement in patients
with lymphoma is more prevalent than generally recognized. Glomer-
ulonephritis may occur in patients with lymphoma as a paraneoplastic
phenomenon. In Hodgkin's disease, the most prevalent form of glomer-
ulonephritis is minimal change glomerulonephritis, although prolifera-
tive, crescentic, memhranous and focal sclerosing forms have been
described. In non-Hodgkins lymphoma, glomerulonephritis is less
prevalent and minimal change glomerulonephritis is infrequently seen.
We describe a patient with non-Hodgkin's lymphoma and acute renal
failure (urea 14.3, creatinine 0.31 mmol/liter) due to focal necrotizing
glomerulonephritis. Treatment of the lymphoma alone with Cyclophos-
phamide, Adriamycin, Vincristine, and Prednisone resulted in complete
resolution of his lymphoma and return to normal of his creatinine
clearance, urine protein excretion and biochemistry. His renal biopsy
prior to initiation of treatment showed a focal necrotizing glomerulone-
phritis. Following induction of remission ofhis lymphoma, renal biopsy
showed only mild mesangial hyperplasia. In summary, focal necrotizing
glomerulonephritis. a relatively uncommon form of nephritis, may
occur in association with lymphoma and resolve on induction of
remission of lymphoma.
